data_6vjq_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6vjq _Structure_validation_residue.Date_analyzed 2020-07-03 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.474 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -67.07 -46.65 73.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 110.002 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.592 ' CD1' ' CB ' ' A' ' 7' ' ' SER . 50.3 pt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.198 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.1 10.75 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.598 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -86.88 -175.04 0.54 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.1 Cg_exo -52.63 -38.38 75.99 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.745 2.297 . . . . 0.0 112.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.612 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.073 0.463 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 C--N 1.304 -1.785 0 C-N-CA 123.008 2.472 . . . . 0.0 111.417 179.708 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.522 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.2 t-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.865 0.364 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.545 ' HB3' ' CB ' ' A' ' 11' ' ' ALA . 53.7 p-10 -135.78 -147.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.542 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . 15.7 p90 -76.28 34.11 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.211 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 27' ' ' CYS . 67.6 mttm -153.44 18.18 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.947 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 27' ' ' CYS . 3.5 m . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.7 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 118.8 -158.3 14.88 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -128.98 147.84 50.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.08 143.53 4.07 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.54 -38.34 83.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.811 2.341 . . . . 0.0 112.001 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.55 -163.11 10.1 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 16' ' ' TYR . . . 69.27 105.31 0.03 OUTLIER Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 18' ' ' CYS . 8.6 t . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.857 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -59.42 -41.29 89.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.601 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 10.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.267 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 81.3 tt0 -88.2 -9.97 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 0.0 110.377 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER 57.39 52.17 5.5 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 7' ' ' SER . 34.1 Cg_endo -66.73 -20.29 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.818 2.345 . . . . 0.0 112.128 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.025 0.44 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.1 Cg_endo . . . . . 0 C--N 1.304 -1.802 0 C-N-CA 123.009 2.473 . . . . 0.0 111.692 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' O ' ' A' ' 20' ' ' LYS . 9.6 t30 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.69 0.281 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.632 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 27.5 t0 -162.03 176.1 11.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.857 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' A' ' 17' ' ' LYS . 60.3 t80 54.25 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.866 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.58 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 8.7 ttmt -111.87 62.83 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.742 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.632 ' SG ' ' O ' ' A' ' 15' ' ' ASP . 1.3 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' CYS . 75.7 mmtt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.763 0.316 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.43 95.17 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.553 ' O ' ' O ' ' A' ' 23' ' ' GLY . 72.8 ttp85 -63.57 -42.91 98.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -54.08 -129.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.16 -38.17 80.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.794 2.329 . . . . 0.0 112.22 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 -142.51 17.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.23 161.58 36.68 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HA ' ' C ' ' A' ' 18' ' ' CYS . 5.5 t . . . . . 0 C--N 1.329 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.588 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 3' ' ' ILE . 53.7 t -47.39 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.575 ' CD1' ' O ' ' A' ' 9' ' ' GLY . 3.6 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 97.9 mt-10 -135.32 16.6 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.52 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.57 176.51 2.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.645 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 46.1 Cg_exo -53.11 -39.49 79.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.828 2.352 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 C-N-CA 123.023 2.482 . . . . 0.0 111.847 179.583 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.561 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.4 t-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.706 0.289 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.589 ' OD2' ' CD2' ' A' ' 16' ' ' TYR . 52.4 p-10 -128.92 -140.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.956 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 52.3 p90 -37.13 139.16 0.24 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 98.6 mttt 49.15 14.28 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.467 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 56.2 mtmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.13 -167.85 11.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 7' ' ' SER . 24.8 tpt180 -115.2 132.05 56.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 6' ' ' GLU . . . 125.26 153.77 8.59 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.55 155.79 54.5 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.914 2.409 . . . . 0.0 112.102 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . 118.47 170.2 14.79 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 25' ' ' GLY . . . -26.88 89.75 0.01 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 1.7 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.825 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 t -79.86 131.35 35.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.582 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 1.1 mp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.885 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.714 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 7' ' ' SER . 19.6 pt-20 -105.47 -6.61 19.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 9.9 p -38.2 154.36 0.13 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 -20.8 55.15 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.822 2.348 . . . . 0.0 111.957 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.953 0.406 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 C--N 1.3 -2.001 0 C-N-CA 122.395 2.063 . . . . 0.0 111.508 179.637 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 23.1 t-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 7' ' ' SER . 11.4 t70 -138.88 -46.23 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 52.0 p90 -135.93 137.53 41.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 26' ' ' GLY . 57.8 mtpt 61.61 29.17 18.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.442 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 68.9 mttm . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.776 0.322 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 15' ' ' ASP . . . -98.29 151.89 19.7 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 89.0 mtm180 -64.56 -39.25 93.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.559 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.04 106.09 0.42 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 36.7 Cg_endo -67.99 -17.91 46.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.845 2.364 . . . . 0.0 112.188 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.6 95.98 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 17' ' ' LYS . . . -120.32 109.83 1.66 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.82 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.642 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -81.96 -47.5 12.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 110.369 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.683 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.183 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.417 ' H ' HG22 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.564 ' OE2' ' O ' ' A' ' 22' ' ' ARG . 17.2 pt-20 -108.95 -8.2 15.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 8' ' ' PRO . 24.4 m -120.15 72.29 18.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.683 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 7' ' ' SER . 48.8 Cg_exo -50.72 -145.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.866 2.377 . . . . 0.0 112.439 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.586 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 11' ' ' ALA . 22.4 Cg_exo . . . . . 0 C--N 1.305 -1.749 0 C-N-CA 123.101 2.534 . . . . 0.0 111.733 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 20' ' ' LYS . 54.4 t30 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 3.1 m-20 -157.43 169.57 24.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.55 ' HB3' ' O ' ' A' ' 15' ' ' ASP . 65.2 t80 77.45 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.704 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.569 ' O ' ' O ' ' A' ' 27' ' ' CYS . 72.5 tttt -118.95 33.28 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 15' ' ' ASP . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 14' ' ' ASN . 64.5 mttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA2' ' OD2' ' A' ' 15' ' ' ASP . . . 125.97 163.17 11.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.564 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mtt-85 -128.13 149.29 50.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.688 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.85 -106.86 1.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -54.34 -34.71 81.54 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.11 10.83 70.87 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -62.83 148.93 49.67 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.6 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.69 0.281 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.53 HD11 ' CB ' ' A' ' 7' ' ' SER . 67.0 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.799 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 83.6 tt0 -113.65 -7.28 13.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.53 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -56.13 145.25 56.53 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.26 -21.17 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.885 2.39 . . . . 0.0 112.096 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.616 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.1 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 C-N-CA 122.789 2.326 . . . . 0.0 111.723 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.0 t30 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.595 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 32.5 m-20 -142.03 145.1 34.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 3.7 t80 87.63 87.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 99.5 mttt 68.13 -8.82 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.709 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.518 ' H ' ' C ' ' A' ' 16' ' ' TYR . 96.8 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.365 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 23.5 tptm . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.847 0.356 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA2' ' OD1' ' A' ' 15' ' ' ASP . . . -59.62 136.8 50.21 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.521 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 78.3 ttt-85 -133.85 125.86 29.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.67 -71.04 0.22 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 55.3 Cg_endo -73.02 160.57 45.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.89 2.393 . . . . 0.0 112.17 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.22 140.59 44.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.58 -171.14 29.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.0 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.525 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.676 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.0 m -60.03 -46.08 90.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.696 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.571 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 96.6 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.169 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.676 ' N ' ' SG ' ' A' ' 1' ' ' CYS . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.442 ' HB2' HG22 ' A' ' 3' ' ' ILE . 76.4 mm-40 -116.27 -4.56 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.817 0.341 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.571 ' OG ' ' CD1' ' A' ' 3' ' ' ILE . 1.3 m -142.33 166.45 21.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 29.3 Cg_endo -64.77 -21.85 64.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.95 2.433 . . . . 0.0 111.77 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 11.3 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 C-N-CA 122.761 2.307 . . . . 0.0 111.786 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 48.4 t30 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.617 0.246 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 78.6 m-20 -155.19 -84.77 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 111.168 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.644 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 17.6 t80 -69.29 135.5 50.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.921 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 98.1 mttt 68.75 18.88 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.425 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 18' ' ' CYS . 64.4 mttp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 15' ' ' ASP . . . -66.34 81.28 0.11 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 23' ' ' GLY . 79.6 mtp85 -65.3 -37.63 87.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -53.06 -134.61 0.0 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -52.87 -39.18 78.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.719 2.279 . . . . 0.0 112.231 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.69 -120.73 1.09 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' LYS . . . 71.06 63.92 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' CYS . 6.3 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.52 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 1.6 t -78.38 -74.07 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.612 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 5' ' ' GLY . 11.3 tp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.352 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.541 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.88 4.56 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.607 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -166.88 -67.0 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.722 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 54.1 Cg_endo -70.43 151.02 65.0 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.767 2.311 . . . . 0.0 112.199 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.52 ' C ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 14' ' ' ASN . 38.3 Cg_exo . . . . . 0 C--N 1.3 -2.0 0 C-N-CA 122.664 2.243 . . . . 0.0 110.972 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 12' ' ' PRO . 7.2 t30 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.884 0.373 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.543 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 87.0 m-20 -143.16 155.66 44.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.78 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER 81.33 79.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.483 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 63.8 mttp 68.35 -5.18 0.95 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.754 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' H ' ' C ' ' A' ' 16' ' ' TYR . 93.2 m . . . . . 0 C--N 1.332 -0.174 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.79 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 14' ' ' ASN . 7.6 tttm . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.669 0.271 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 27' ' ' CYS . . . -163.28 138.45 5.33 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -81.7 -20.54 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.835 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -42.88 144.15 1.26 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.25 -25.04 64.89 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.856 2.37 . . . . 0.0 112.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 26' ' ' GLY . . . -96.82 146.36 18.25 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 25' ' ' GLY . . . 35.24 -160.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.593 ' O ' ' O ' ' A' ' 21' ' ' GLY . 97.6 m . . . . . 0 C--N 1.326 -0.416 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.424 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -87.74 -45.28 10.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.68 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 3.0 tt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.295 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.0 tp10 -107.72 -10.05 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.225 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -74.44 154.06 87.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.577 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.31 -20.79 55.17 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.814 2.342 . . . . 0.0 112.062 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 14' ' ' ASN . 17.1 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.586 2.191 . . . . 0.0 111.578 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.582 ' O ' ' CA ' ' A' ' 21' ' ' GLY . 66.3 t30 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.737 0.303 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 3' ' ' ILE . 64.5 t0 -142.52 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 23.4 t80 -80.05 131.29 35.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 15.4 tttp 78.84 1.49 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' C ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.326 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 14' ' ' ASN . . . -68.04 -42.8 83.97 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 55.52 79.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.62 -163.4 11.83 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.91 -21.54 57.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.895 2.397 . . . . 0.0 112.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.9 -156.19 7.45 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . 62.94 -130.47 42.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HA ' ' C ' ' A' ' 18' ' ' CYS . 14.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.1 m -88.81 -74.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.56 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.328 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -93.61 -66.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.307 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 155.8 -64.15 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.76 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 35.3 Cg_endo -67.26 -17.38 49.91 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.967 2.444 . . . . 0.0 112.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.448 ' N ' ' OE1' ' A' ' 6' ' ' GLU . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.779 0.323 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 14' ' ' ASN . 15.3 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 12' ' ' PRO . 47.6 t30 . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.582 ' OD1' ' CA ' ' A' ' 21' ' ' GLY . 31.2 t70 -155.08 -86.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.645 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 56.8 t80 -70.96 131.48 43.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 26' ' ' GLY . 23.4 mtpt 61.43 33.14 18.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.046 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.582 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.825 0.345 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -96.82 120.79 6.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' GLY . 90.1 mtm180 -96.87 0.63 49.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -55.69 -152.74 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.45 -39.32 82.43 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.839 2.359 . . . . 0.0 112.153 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.79 -167.84 38.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.574 ' HA3' ' CD1' ' A' ' 16' ' ' TYR . . . 99.81 103.67 2.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.444 ' C ' ' HA ' ' A' ' 17' ' ' LYS . 7.6 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 110.665 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -79.8 -46.03 17.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.333 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.563 HD12 ' CD1' ' A' ' 16' ' ' TYR . 4.2 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.488 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -100.83 -5.93 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.06 0.457 . . . . 0.0 110.1 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -72.11 176.4 2.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.377 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 9' ' ' GLY . 56.1 Cg_endo -71.77 159.23 51.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.66 2.24 . . . . 0.0 111.88 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ASN . 32.9 Cg_exo . . . . . 0 C--N 1.301 -1.93 0 C-N-CA 122.54 2.16 . . . . 0.0 111.036 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' PRO . 35.6 t30 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.799 0.333 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' A' ' 16' ' ' TYR . 54.0 p-10 -150.2 -136.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.563 ' CD1' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER 26.68 -93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.592 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ASP . 56.5 mtmt -130.09 76.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.782 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 15' ' ' ASP . 3.1 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.75 0.309 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.99 171.45 16.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -131.62 146.36 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.48 151.73 8.3 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.99 144.81 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.977 2.451 . . . . 0.0 112.1 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.79 152.9 22.77 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.77 -172.59 14.47 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 8' ' ' PRO . 10.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.4 -37.69 10.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.173 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 8' ' ' PRO . 40.0 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.963 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.26 -5.49 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.13 80.69 0.41 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.341 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 12.1 Cg_endo -56.53 -41.46 75.8 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 112.212 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 9' ' ' GLY . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 C-N-CA 122.888 2.392 . . . . 0.0 111.747 179.839 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' OD1' ' CB ' ' A' ' 20' ' ' LYS . 65.0 t30 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.544 0.211 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.51 ' OD2' HG12 ' A' ' 3' ' ' ILE . 63.8 t0 -141.52 -107.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.137 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 18' ' ' CYS . 39.7 p90 -53.94 144.67 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.772 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.492 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 99.0 mttt 32.61 30.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.594 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' TYR . 1.1 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.663 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 57.8 mtpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.802 0.334 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.92 173.09 42.83 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -112.28 131.65 55.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.7 -118.6 0.88 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 25' ' ' GLY . 59.9 Cg_endo -73.2 157.4 50.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.823 2.349 . . . . 0.0 112.183 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 24' ' ' PRO . . . -51.52 -162.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 17' ' ' LYS . . . 82.27 20.34 62.74 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.432 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.646 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.559 ' O ' HG21 ' A' ' 3' ' ' ILE . 2.7 t -79.01 134.48 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 5' ' ' GLY . 1.8 tp . . . . . 0 C--N 1.331 -0.207 0 O-C-N 123.309 0.381 . . . . 0.0 110.246 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.582 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -103.86 -5.01 22.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 110.52 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.13 172.79 1.72 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -53.39 -38.18 82.38 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.866 2.377 . . . . 0.0 112.182 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.996 0.426 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 14' ' ' ASN . 35.2 Cg_exo . . . . . 0 C--N 1.301 -1.949 0 C-N-CA 122.718 2.279 . . . . 0.0 111.782 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 20' ' ' LYS . 61.4 t-20 . . . . . 0 C--O 1.228 -0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.615 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 98.7 m-20 -118.69 155.4 31.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.609 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.615 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 92.56 11.58 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.772 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 56.8 mttp 88.21 39.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.42 0.45 . . . . 0.0 110.905 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 179.77 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 14' ' ' ASN . 57.8 mtpt . . . . . 0 N--CA 1.46 0.048 0 CA-C-O 120.901 0.381 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.89 149.35 5.33 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -94.67 -5.44 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.781 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.87 159.85 42.35 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.69 143.72 47.13 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.906 2.404 . . . . 0.0 111.979 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.06 -174.97 19.83 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.638 ' O ' ' SG ' ' A' ' 27' ' ' CYS . . . 65.59 28.45 73.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.638 ' SG ' ' O ' ' A' ' 26' ' ' GLY . 2.1 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.549 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.1 m -63.44 -45.07 92.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.224 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 15' ' ' ASP . 85.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.381 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.409 ' HG2' HG21 ' A' ' 3' ' ' ILE . 18.5 pt-20 -108.8 -4.15 17.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.369 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.603 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -143.75 -175.48 0.48 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.763 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.4 Cg_exo -52.4 -38.2 73.35 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.991 2.46 . . . . 0.0 112.064 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.888 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.095 0.474 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo . . . . . 0 C--N 1.301 -1.929 0 C-N-CA 122.849 2.366 . . . . 0.0 111.915 179.682 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB3' ' CB ' ' A' ' 11' ' ' ALA . 63.6 t30 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.537 ' CG ' ' HA3' ' A' ' 21' ' ' GLY . 1.0 OUTLIER 68.88 -76.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.794 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 25.0 t80 -70.88 126.47 29.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.521 ' HE3' ' CE2' ' A' ' 16' ' ' TYR . 98.0 mttt 58.29 3.67 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 18' ' ' CYS . 99.3 mttt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.537 ' HA3' ' CG ' ' A' ' 15' ' ' ASP . . . -106.62 -175.19 23.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.31 145.31 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.62 36.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -53.29 -38.33 81.81 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.863 2.375 . . . . 0.0 112.062 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.94 -170.05 32.2 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 79.02 11.49 85.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 0.0 110.477 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.432 ' CB ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -87.65 -83.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.878 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.579 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 5.6 pt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.094 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.529 ' N ' HG13 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.07 6.08 28.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.756 0.312 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.579 ' OG ' ' CD1' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -70.82 177.77 1.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.1 Cg_exo -53.89 -38.18 85.81 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.766 2.311 . . . . 0.0 112.014 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.304 -1.793 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.66 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 58.6 t-20 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.702 0.287 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 17' ' ' LYS . 4.5 p-10 -119.74 94.94 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.5 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 51.0 p90 32.52 28.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.13 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.629 ' N ' ' O ' ' A' ' 15' ' ' ASP . 83.0 mttt -152.35 24.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.736 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' CYS . 99.0 mttt . . . . . 0 CA--C 1.526 0.054 0 CA-C-O 120.793 0.33 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.16 157.17 8.32 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -125.99 135.39 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.69 -103.44 1.93 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.59 150.73 51.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.877 2.385 . . . . 0.0 112.132 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.71 47.25 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 167.19 99.38 0.13 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 110.574 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -92.62 -57.88 2.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.139 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.55 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.052 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.86 14.53 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.496 ' HB2' ' CD ' ' A' ' 8' ' ' PRO . 69.5 p -103.35 171.65 4.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.555 ' O ' ' O ' ' A' ' 9' ' ' GLY . 23.9 Cg_exo -62.09 146.66 96.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 123.017 2.478 . . . . 0.0 112.014 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.515 ' C ' ' H ' ' A' ' 14' ' ' ASN . 9.9 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.874 2.383 . . . . 0.0 111.721 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.585 ' O ' ' CB ' ' A' ' 20' ' ' LYS . 25.8 t-20 . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.641 0.258 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.583 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 62.8 m-20 -161.97 175.5 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.514 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 70.0 t80 72.45 -64.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' CA ' ' O ' ' A' ' 27' ' ' CYS . 60.6 mttm -153.92 66.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 74.8 mmtt . . . . . 0 N--CA 1.46 0.068 0 CA-C-O 120.929 0.395 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.86 112.01 1.12 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -66.54 -38.96 88.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.756 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.75 -135.0 5.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.577 ' O ' ' C ' ' A' ' 25' ' ' GLY . 36.8 Cg_endo -66.91 -19.49 52.27 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.87 2.38 . . . . 0.0 112.25 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 24' ' ' PRO . . . -19.48 130.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -78.6 175.89 54.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 17' ' ' LYS . 5.9 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.567 ' SG ' ' HG3' ' A' ' 8' ' ' PRO . 9.0 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.663 ' SG ' ' CD1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -95.6 -39.33 9.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.033 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.663 ' CD1' ' SG ' ' A' ' 2' ' ' CYS . 1.1 mp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.2 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.4 tp10 -125.51 -13.25 6.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.9 0.381 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.556 ' O ' ' OG ' ' A' ' 7' ' ' SER . 6.1 p -145.57 73.68 13.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 31.9 Cg_exo -54.92 -149.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.904 2.402 . . . . 0.0 112.202 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 15' ' ' ASP . . . . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 121.011 0.434 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.2 Cg_endo . . . . . 0 C--N 1.304 -1.806 0 C-N-CA 122.781 2.32 . . . . 0.0 112.074 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG ' ' A' ' 7' ' ' SER . 11.9 t30 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.701 0.286 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.588 ' OD1' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -156.81 66.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.599 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.559 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 4.1 t80 174.08 84.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.869 0.366 . . . . 0.0 110.491 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' H ' ' CZ ' ' A' ' 22' ' ' ARG . 97.4 mttt 53.46 7.89 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.333 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' H ' ' C ' ' A' ' 16' ' ' TYR . 38.3 m . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 21' ' ' GLY . 60.5 tptt . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' OD1' ' A' ' 15' ' ' ASP . . . -57.06 161.94 7.74 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.588 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 38.9 mtm-85 -153.81 -164.12 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.719 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.88 -78.79 1.41 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -53.52 -38.83 83.79 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.86 2.373 . . . . 0.0 112.317 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.82 152.39 5.67 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.449 ' HA3' HH21 ' A' ' 22' ' ' ARG . . . -173.35 -178.36 43.27 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 110.765 -179.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -93.02 -45.58 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.593 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.669 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 3.7 tp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.5 tp10 -109.23 -10.66 14.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -84.4 165.84 36.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.61 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -53.69 -38.36 84.54 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.763 2.308 . . . . 0.0 112.023 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.897 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.564 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.667 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 24.6 Cg_exo . . . . . 0 C--N 1.301 -1.945 0 C-N-CA 122.763 2.309 . . . . 0.0 112.158 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.564 ' HB3' ' CB ' ' A' ' 11' ' ' ALA . 12.5 t-20 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.629 0.252 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.576 ' OD2' ' CG2' ' A' ' 3' ' ' ILE . 61.6 t0 -156.72 -87.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.378 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.641 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 22.8 t80 -68.57 130.73 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt 68.7 10.2 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.256 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.7 tttp . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.783 0.325 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.92 156.03 20.02 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 62.5 ttp180 -61.61 -43.12 99.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.22 126.14 9.23 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.99 156.06 47.74 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.944 2.43 . . . . 0.0 112.39 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.33 145.08 18.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 63.72 27.58 71.3 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.219 0.533 . . . . 0.0 111.18 -179.421 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -83.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.516 HG12 ' OD2' ' A' ' 15' ' ' ASP . 10.7 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.273 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.504 ' HA3' ' CG ' ' A' ' 22' ' ' ARG . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.52 -5.32 22.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -58.38 -175.51 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 45.7 Cg_exo -53.27 -38.08 81.44 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.746 2.298 . . . . 0.0 111.896 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.649 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.411 ' C ' ' N ' ' A' ' 14' ' ' ASN . 18.5 Cg_endo . . . . . 0 C--N 1.306 -1.692 0 C-N-CA 122.608 2.205 . . . . 0.0 111.009 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.588 ' OD1' ' CE ' ' A' ' 20' ' ' LYS . 2.0 t-20 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.761 0.315 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.623 ' O ' ' C ' ' A' ' 16' ' ' TYR . 67.6 t0 176.92 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.623 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 9.25 -82.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.266 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ASP . 68.5 mttm -138.63 29.61 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.455 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' CE ' ' OD1' ' A' ' 14' ' ' ASN . 16.6 mttm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.968 0.413 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.55 125.35 2.79 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' CG ' ' HA3' ' A' ' 5' ' ' GLY . 62.2 ttp180 -63.41 -43.06 98.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.741 0.305 . . . . 0.0 110.692 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.68 -120.68 1.65 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.32 -38.7 82.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.717 2.278 . . . . 0.0 112.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.31 126.28 1.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' TYR . . . -133.63 -68.89 0.08 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.667 ' SG ' ' C ' ' A' ' 18' ' ' CYS . 43.3 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.638 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -79.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.419 . . . . 0.0 109.934 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.541 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.901 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.3 tp10 -106.37 -11.32 16.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 110.604 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.516 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 1.3 m -60.92 125.8 84.23 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -53.51 -39.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.859 2.373 . . . . 0.0 112.141 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.042 0.448 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.563 ' C ' ' N ' ' A' ' 14' ' ' ASN . 11.8 Cg_endo . . . . . 0 C--N 1.301 -1.931 0 C-N-CA 122.792 2.328 . . . . 0.0 111.817 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.563 ' N ' ' C ' ' A' ' 12' ' ' PRO . 66.2 t30 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.666 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 30.2 t0 175.07 173.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.78 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.666 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 16.9 p90 48.71 11.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 51.3 mttt 150.33 45.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.437 0.46 . . . . 0.0 110.532 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 20' ' ' LYS . 1.1 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.9 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.574 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -158.34 -142.52 3.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -61.12 -42.44 98.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.653 0.263 . . . . 0.0 110.54 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.94 -71.16 0.1 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.54 -20.25 47.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.872 2.381 . . . . 0.0 112.105 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 21' ' ' GLY . . . -168.11 -141.14 3.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 21' ' ' GLY . . . 86.66 13.65 66.95 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 110.643 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.474 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -67.07 -46.65 73.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 110.002 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.629 ' O ' ' C ' ' A' ' 4' ' ' DBB . 50.3 pt -130.29 3.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.198 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.629 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -133.57 -127.87 2.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.806 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.1 10.75 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.598 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -86.88 -175.04 0.54 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.1 Cg_exo -52.63 -38.38 75.99 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.745 2.297 . . . . 0.0 112.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 134.08 -124.58 3.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.674 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . 26.53 69.24 0.45 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.566 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 13' ' ' DBB . 29.5 Cg_endo -65.97 -13.43 39.79 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.008 2.472 . . . . 0.0 111.417 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.599 ' HB2' ' O ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.554 ' N ' ' HG2' ' A' ' 13' ' ' DBB . 62.2 t-20 -135.69 35.84 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.781 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.569 ' OD1' ' CG ' ' A' ' 13' ' ' DBB . 53.7 p-10 -135.78 -147.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.542 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . 15.7 p90 -76.28 34.11 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.211 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 27' ' ' CYS . 67.6 mttm -153.44 18.18 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.947 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 27' ' ' CYS . 3.5 m -155.35 34.96 0.37 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.564 ' C ' ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.7 mttt -139.9 148.63 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.641 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 118.8 -158.3 14.88 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -128.98 147.84 50.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.08 143.53 4.07 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.54 -38.34 83.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.811 2.341 . . . . 0.0 112.001 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.55 -163.11 10.1 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 16' ' ' TYR . . . 69.27 105.31 0.03 OUTLIER Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' SG ' ' CE1' ' A' ' 28' ' ' TYR . 8.6 t -128.73 -72.62 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.707 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 98.8 m-85 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.554 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -59.42 -41.29 89.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.601 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 10.0 tp -109.91 2.75 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.267 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.91 -122.44 2.76 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 81.3 tt0 -88.2 -9.97 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 0.0 110.377 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER 57.39 52.17 5.5 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 7' ' ' SER . 34.1 Cg_endo -66.73 -20.29 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.818 2.345 . . . . 0.0 112.128 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . 166.46 55.78 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.49 ' O ' HD12 ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . . . 62.45 57.58 2.55 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.513 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' C ' ' CG ' ' A' ' 13' ' ' DBB . 37.1 Cg_endo -69.26 -10.22 28.39 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.009 2.473 . . . . 0.0 111.692 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.567 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' O ' ' A' ' 20' ' ' LYS . 9.6 t30 -122.37 -1.72 9.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.676 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.632 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 27.5 t0 -162.03 176.1 11.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.857 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' A' ' 17' ' ' LYS . 60.3 t80 54.25 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.866 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.58 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 8.7 ttmt -111.87 62.83 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.742 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.632 ' SG ' ' O ' ' A' ' 15' ' ' ASP . 1.3 m -155.92 139.32 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.508 ' C ' ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' CYS . 75.7 mmtt -116.14 119.57 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.43 95.17 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.553 ' O ' ' O ' ' A' ' 23' ' ' GLY . 72.8 ttp85 -63.57 -42.91 98.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -54.08 -129.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.16 -38.17 80.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.794 2.329 . . . . 0.0 112.22 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 -142.51 17.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.23 161.58 36.68 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 5.5 t -124.63 170.59 10.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.588 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.676 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 38.9 p90 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.694 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 10' ' ' DAL . 53.7 t -47.39 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.575 ' CD1' ' O ' ' A' ' 9' ' ' GLY . 3.6 mp -90.57 -39.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.16 22.08 79.23 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 97.9 mt-10 -135.32 16.6 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.52 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.57 176.51 2.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.645 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 46.1 Cg_exo -53.11 -39.49 79.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.828 2.352 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.71 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 146.15 -160.68 28.21 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.71 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . 37.82 71.49 1.02 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.536 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 13' ' ' DBB . 19.2 Cg_endo -60.2 -18.77 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.023 2.482 . . . . 0.0 111.847 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.658 ' C ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.561 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.4 t-20 -118.26 13.83 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.523 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.589 ' OD2' ' CD2' ' A' ' 16' ' ' TYR . 52.4 p-10 -128.92 -140.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.956 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 52.3 p90 -37.13 139.16 0.24 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 98.6 mttt 49.15 14.28 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 0.7 OUTLIER -137.42 -16.08 1.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.467 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.578 ' N ' ' O ' ' A' ' 15' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 56.2 mtmt 66.0 20.05 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.381 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.13 -167.85 11.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 7' ' ' SER . 24.8 tpt180 -115.2 132.05 56.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 6' ' ' GLU . . . 125.26 153.77 8.59 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.55 155.79 54.5 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.914 2.409 . . . . 0.0 112.102 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . 118.47 170.2 14.79 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 25' ' ' GLY . . . -26.88 89.75 0.01 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 1.7 t -149.07 155.56 40.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.825 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CG ' ' C ' ' A' ' 27' ' ' CYS . 6.1 m-85 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.479 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 4' ' ' DBB . 2.7 t -79.86 131.35 35.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.153 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.606 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.1 mp 63.05 0.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.885 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.606 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -129.86 -144.18 5.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 7' ' ' SER . 19.6 pt-20 -105.47 -6.61 19.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 9.9 p -38.2 154.36 0.13 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 -20.8 55.15 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.822 2.348 . . . . 0.0 111.957 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . 172.35 -168.39 41.46 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.616 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . -111.36 71.87 0.88 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.157 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.616 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 35.5 Cg_exo -48.54 135.32 26.93 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.395 2.063 . . . . 0.0 111.508 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.539 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 23.1 t-20 -148.59 13.4 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.565 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 7' ' ' SER . 11.4 t70 -138.88 -46.23 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 52.0 p90 -135.93 137.53 41.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 57.8 mtpt 61.61 29.17 18.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -130.89 -22.53 2.6 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.442 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.589 ' CG ' ' O ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 68.9 mttm -95.37 -8.3 36.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.448 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 15' ' ' ASP . . . -98.29 151.89 19.7 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.481 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 89.0 mtm180 -64.56 -39.25 93.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.559 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.04 106.09 0.42 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 36.7 Cg_endo -67.99 -17.91 46.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.845 2.364 . . . . 0.0 112.188 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.6 95.98 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 17' ' ' LYS . . . -120.32 109.83 1.66 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.721 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 35.0 t -137.23 125.79 23.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.82 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.721 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.11 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.642 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -81.96 -47.5 12.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 110.369 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.683 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 11.1 tp -97.22 -5.18 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.183 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.583 ' HG2' ' N ' ' A' ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -123.89 -148.64 7.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.564 ' OE2' ' O ' ' A' ' 22' ' ' ARG . 17.2 pt-20 -108.95 -8.2 15.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 8' ' ' PRO . 24.4 m -120.15 72.29 18.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.683 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 7' ' ' SER . 48.8 Cg_exo -50.72 -145.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.866 2.377 . . . . 0.0 112.439 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.32 16.8 70.6 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.587 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.586 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . 25.86 58.12 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.822 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 22.4 Cg_exo -60.9 -3.4 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.101 2.534 . . . . 0.0 111.733 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.658 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 20' ' ' LYS . 54.4 t30 -118.53 -11.97 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.764 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 3.1 m-20 -157.43 169.57 24.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.55 ' HB3' ' O ' ' A' ' 15' ' ' ASP . 65.2 t80 77.45 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.704 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.569 ' O ' ' O ' ' A' ' 27' ' ' CYS . 72.5 tttt -118.95 33.28 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.8 OUTLIER -120.85 147.01 45.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.467 ' CG ' ' O ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 14' ' ' ASN . 64.5 mttp -110.01 149.92 29.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA2' ' OD2' ' A' ' 15' ' ' ASP . . . 125.97 163.17 11.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.564 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mtt-85 -128.13 149.29 50.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.688 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.85 -106.86 1.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -54.34 -34.71 81.54 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.11 10.83 70.87 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -62.83 148.93 49.67 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' O ' ' C ' ' A' ' 28' ' ' TYR . 9.6 t -124.3 165.69 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.69 0.281 . . . . 0.0 110.53 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.584 ' C ' ' O ' ' A' ' 27' ' ' CYS . 99.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.812 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.53 HD11 ' CB ' ' A' ' 7' ' ' SER . 67.0 mt -65.55 -42.83 93.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.799 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.42 -110.45 1.53 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 83.6 tt0 -113.65 -7.28 13.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.53 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -56.13 145.25 56.53 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.26 -21.17 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.885 2.39 . . . . 0.0 112.096 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.658 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 156.34 -158.55 28.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.658 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . 38.1 66.96 2.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.593 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.616 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.1 Cg_endo -58.02 127.11 23.77 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.789 2.326 . . . . 0.0 111.723 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.615 ' C ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.0 t30 -103.5 -40.42 6.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.597 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.595 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 32.5 m-20 -142.03 145.1 34.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 3.7 t80 87.63 87.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 99.5 mttt 68.13 -8.82 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.709 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.615 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 96.8 m -64.35 -35.31 80.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.365 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.534 ' HB2' ' C ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 23.5 tptm -105.56 -4.0 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.52 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 28' ' ' TYR . . . -59.62 136.8 50.21 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.521 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 78.3 ttt-85 -133.85 125.86 29.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.67 -71.04 0.22 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 55.3 Cg_endo -73.02 160.57 45.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.89 2.393 . . . . 0.0 112.17 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.455 ' HA2' ' OH ' ' A' ' 28' ' ' TYR . . . -57.22 140.59 44.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.554 ' C ' ' CE2' ' A' ' 28' ' ' TYR . . . 149.58 -171.14 29.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.63 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 31.0 p -82.8 135.27 35.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.525 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.63 ' CD2' ' O ' ' A' ' 27' ' ' CYS . 4.2 p90 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.664 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.676 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.0 m -60.03 -46.08 90.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.696 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.571 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 96.6 mt -100.89 -41.19 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.169 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.676 ' N ' ' SG ' ' A' ' 1' ' ' CYS . . . 75.12 23.0 75.47 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' HB2' HG22 ' A' ' 3' ' ' ILE . 76.4 mm-40 -116.27 -4.56 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.817 0.341 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.571 ' OG ' ' CD1' ' A' ' 3' ' ' ILE . 1.3 m -142.33 166.45 21.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 29.3 Cg_endo -64.77 -21.85 64.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.95 2.433 . . . . 0.0 111.77 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.672 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 149.69 -158.7 27.77 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.672 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.555 ' C ' ' O ' ' A' ' 10' ' ' DAL . . . 25.04 71.64 0.36 Allowed Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 11.3 Cg_endo -56.34 -88.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.761 2.307 . . . . 0.0 111.786 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.549 ' CG ' ' C ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 48.4 t30 -98.66 -3.29 36.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.954 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 78.6 m-20 -155.19 -84.77 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 111.168 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.644 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 17.6 t80 -69.29 135.5 50.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.921 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 28' ' ' TYR . 98.1 mttt 68.75 18.88 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -146.15 150.23 35.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.425 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.459 ' O ' ' CG ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 18' ' ' CYS . 64.4 mttp -92.14 -5.89 51.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 15' ' ' ASP . . . -66.34 81.28 0.11 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 23' ' ' GLY . 79.6 mtp85 -65.3 -37.63 87.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -53.06 -134.61 0.0 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -52.87 -39.18 78.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.719 2.279 . . . . 0.0 112.231 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.69 -120.73 1.09 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' LYS . . . 71.06 63.92 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' C ' ' A' ' 28' ' ' TYR . 6.3 t -83.29 143.06 30.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 110.593 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.56 ' C ' ' O ' ' A' ' 27' ' ' CYS . 39.2 p90 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.757 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.52 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 1.6 t -78.38 -74.07 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.612 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.652 ' O ' ' C ' ' A' ' 4' ' ' DBB . 11.3 tp -104.72 25.03 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.352 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.652 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -83.16 -130.94 1.68 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.88 4.56 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.607 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -166.88 -67.0 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.722 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 54.1 Cg_endo -70.43 151.02 65.0 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.767 2.311 . . . . 0.0 112.199 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -85.72 -125.02 1.55 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.666 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.576 ' C ' ' O ' ' A' ' 10' ' ' DAL . . . 24.36 64.58 0.41 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 14' ' ' ASN . 38.3 Cg_exo -54.24 136.81 69.6 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 122.664 2.243 . . . . 0.0 110.972 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.626 ' C ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 12' ' ' PRO . 7.2 t30 -103.49 -36.98 7.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.625 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.543 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 87.0 m-20 -143.16 155.66 44.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.78 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER 81.33 79.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.483 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 63.8 mttp 68.35 -5.18 0.95 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.754 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.626 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 93.2 m -64.55 -44.41 90.86 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.79 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.505 ' H ' ' CB ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 14' ' ' ASN . 7.6 tttm -152.54 72.1 0.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 27' ' ' CYS . . . -163.28 138.45 5.33 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -81.7 -20.54 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.835 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 28' ' ' TYR . . . -42.88 144.15 1.26 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.25 -25.04 64.89 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.856 2.37 . . . . 0.0 112.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.639 ' C ' ' CE1' ' A' ' 28' ' ' TYR . . . -96.82 146.36 18.25 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 28' ' ' TYR . . . 35.24 -160.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' O ' ' O ' ' A' ' 21' ' ' GLY . 97.6 m -64.91 -38.64 91.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.424 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.639 ' CE1' ' C ' ' A' ' 25' ' ' GLY . 14.5 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.595 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -87.74 -45.28 10.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.68 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 3.0 tt -119.78 9.31 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.662 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.594 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -131.13 -124.58 2.6 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.0 tp10 -107.72 -10.05 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.225 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -74.44 154.06 87.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.577 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.31 -20.79 55.17 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.814 2.342 . . . . 0.0 112.062 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . 165.36 -162.3 35.64 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . -112.69 76.97 2.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' ASN . 17.1 Cg_endo -59.05 143.27 99.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.586 2.191 . . . . 0.0 111.578 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.673 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.582 ' O ' ' CA ' ' A' ' 21' ' ' GLY . 66.3 t30 -118.93 4.81 11.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 3' ' ' ILE . 64.5 t0 -142.52 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.597 ' O ' ' CG ' ' A' ' 13' ' ' DBB . 23.4 t80 -80.05 131.29 35.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.573 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 15.4 tttp 78.84 1.49 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.673 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 1.3 m -132.98 120.94 22.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.326 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.59 ' HA ' ' CE1' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -64.35 -43.75 93.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.813 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 14' ' ' ASN . . . -68.04 -42.8 83.97 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.537 ' CA ' ' HG3' ' A' ' 19' ' ' DBB . 76.0 ttt180 55.52 79.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.693 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.62 -163.4 11.83 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.91 -21.54 57.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.895 2.397 . . . . 0.0 112.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.9 -156.19 7.45 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . 62.94 -130.47 42.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.574 ' O ' ' C ' ' A' ' 28' ' ' TYR . 14.8 t 71.52 138.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.59 ' CE1' ' HA ' ' A' ' 19' ' ' DBB . 93.6 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.752 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.1 m -88.81 -74.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.66 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.2 mp -70.91 -3.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.66 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -165.45 -16.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -93.61 -66.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.307 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 155.8 -64.15 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.76 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 35.3 Cg_endo -67.26 -17.38 49.91 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.967 2.444 . . . . 0.0 112.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.653 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 72.22 -128.63 13.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.653 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' C ' ' O ' ' A' ' 10' ' ' DAL . . . 26.99 66.15 0.54 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.406 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 14' ' ' ASN . 15.3 Cg_endo -58.4 134.71 63.1 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.515 ' C ' ' O ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 12' ' ' PRO . 47.6 t30 -115.48 0.71 13.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.673 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.582 ' OD1' ' CA ' ' A' ' 21' ' ' GLY . 31.2 t70 -155.08 -86.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.645 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 56.8 t80 -70.96 131.48 43.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 23.4 mtpt 61.43 33.14 18.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.046 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -136.7 -18.82 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.582 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.611 ' CG ' ' O ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.8 -5.7 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.675 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -96.82 120.79 6.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' GLY . 90.1 mtm180 -96.87 0.63 49.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -55.69 -152.74 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.45 -39.32 82.43 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.839 2.359 . . . . 0.0 112.153 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.79 -167.84 38.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.574 ' HA3' ' CD1' ' A' ' 16' ' ' TYR . . . 99.81 103.67 2.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 28' ' ' TYR . 7.6 t -135.67 133.78 38.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 110.665 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.58 ' N ' ' N ' ' A' ' 18' ' ' CYS . 95.1 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.627 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -79.8 -46.03 17.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.333 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.672 ' O ' ' C ' ' A' ' 4' ' ' DBB . 4.2 tp -121.42 5.79 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.488 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.672 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.619 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -160.81 -148.88 5.42 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -100.83 -5.93 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.06 0.457 . . . . 0.0 110.1 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -72.11 176.4 2.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.377 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 9' ' ' GLY . 56.1 Cg_endo -71.77 159.23 51.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.66 2.24 . . . . 0.0 111.88 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.689 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -51.71 -156.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.689 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . . . 45.69 61.99 11.6 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ASN . 32.9 Cg_exo -51.91 135.06 50.26 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.54 2.16 . . . . 0.0 111.036 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.524 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' PRO . 35.6 t30 -119.19 -1.64 10.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.698 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' A' ' 16' ' ' TYR . 54.0 p-10 -150.2 -136.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.563 ' CD1' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER 26.68 -93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.592 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ASP . 56.5 mtmt -130.09 76.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.782 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 3.1 m -135.14 -1.74 2.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.497 ' H ' ' CB ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 58.1 tptt -147.67 147.03 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.578 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.635 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 114.99 171.45 16.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -131.62 146.36 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.48 151.73 8.3 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.99 144.81 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.977 2.451 . . . . 0.0 112.1 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.79 152.9 22.77 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.77 -172.59 14.47 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.635 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -57.39 -178.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CD2' ' O ' ' A' ' 27' ' ' CYS . 55.6 p90 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 8' ' ' PRO . 10.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.4 -37.69 10.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.173 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.675 ' O ' ' C ' ' A' ' 4' ' ' DBB . 40.0 mt -103.86 -1.46 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.963 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.675 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -129.62 -97.01 0.81 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.26 -5.49 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.13 80.69 0.41 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.341 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.618 ' O ' ' N ' ' A' ' 10' ' ' DAL . 12.1 Cg_endo -56.53 -41.46 75.8 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 112.212 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . 34.75 24.62 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.618 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 9' ' ' GLY . . . 38.92 62.91 4.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.767 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 13' ' ' DBB . 31.5 Cg_endo -66.74 -19.5 53.29 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.888 2.392 . . . . 0.0 111.747 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.582 ' C ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' OD1' ' CB ' ' A' ' 20' ' ' LYS . 65.0 t30 -120.47 17.83 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.971 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.51 ' O ' ' HG1' ' A' ' 19' ' ' DBB . 63.8 t0 -141.52 -107.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.137 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 18' ' ' CYS . 39.7 p90 -53.94 144.67 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.772 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.492 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 99.0 mttt 32.61 30.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.594 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' TYR . 1.1 m -141.44 -27.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.556 ' CA ' ' HA ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 57.8 mtpt 52.07 27.43 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.191 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.92 173.09 42.83 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -112.28 131.65 55.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.7 -118.6 0.88 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 25' ' ' GLY . 59.9 Cg_endo -73.2 157.4 50.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.823 2.349 . . . . 0.0 112.183 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 24' ' ' PRO . . . -51.52 -162.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 17' ' ' LYS . . . 82.27 20.34 62.74 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' HA ' ' CA ' ' A' ' 19' ' ' DBB . 0.0 OUTLIER -99.72 139.22 35.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.432 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.512 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.646 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.559 ' O ' HG21 ' A' ' 3' ' ' ILE . 2.7 t -79.01 134.48 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.652 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.8 tp 54.63 9.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 123.309 0.381 . . . . 0.0 110.246 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.652 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -108.88 -158.73 19.03 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -103.86 -5.01 22.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 110.52 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.13 172.79 1.72 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -53.39 -38.18 82.38 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.866 2.377 . . . . 0.0 112.182 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.547 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 153.02 -164.88 31.01 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.622 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . -117.78 69.24 6.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.583 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.622 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 35.2 Cg_exo -52.6 137.84 58.38 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.718 2.279 . . . . 0.0 111.782 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.658 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 20' ' ' LYS . 61.4 t-20 -116.78 -28.15 6.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.532 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.615 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 98.7 m-20 -118.69 155.4 31.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.609 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.615 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 92.56 11.58 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.772 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 56.8 mttp 88.21 39.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.42 0.45 . . . . 0.0 110.905 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 10.9 t -82.95 -16.68 46.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 14' ' ' ASN . 57.8 mtpt -138.52 159.18 42.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.764 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' C ' ' HB3' ' A' ' 28' ' ' TYR . . . 139.89 149.35 5.33 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -94.67 -5.44 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.781 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 28' ' ' TYR . . . -80.87 159.85 42.35 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.69 143.72 47.13 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.906 2.404 . . . . 0.0 111.979 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.06 -174.97 19.83 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.638 ' O ' ' SG ' ' A' ' 27' ' ' CYS . . . 65.59 28.45 73.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.638 ' SG ' ' O ' ' A' ' 26' ' ' GLY . 2.1 p 51.94 11.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.549 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 26' ' ' GLY . 11.6 m-30 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.702 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.439 ' CB ' ' H ' ' A' ' 10' ' ' DAL . 3.1 m -63.44 -45.07 92.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.224 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 15' ' ' ASP . 85.5 mt -117.86 -29.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.381 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.87 25.82 55.04 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.409 ' HG2' HG21 ' A' ' 3' ' ' ILE . 18.5 pt-20 -108.8 -4.15 17.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.369 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.603 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -143.75 -175.48 0.48 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.763 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.4 Cg_exo -52.4 -38.2 73.35 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.991 2.46 . . . . 0.0 112.064 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.647 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 118.48 168.49 14.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.647 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -112.07 75.33 1.56 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 110.488 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.23 142.07 97.1 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.849 2.366 . . . . 0.0 111.915 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.708 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB3' ' CB ' ' A' ' 11' ' ' ALA . 63.6 t30 -125.66 123.89 39.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.437 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.537 ' CG ' ' HA3' ' A' ' 21' ' ' GLY . 1.0 OUTLIER 68.88 -76.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.794 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 25.0 t80 -70.88 126.47 29.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' C ' ' HG3' ' A' ' 13' ' ' DBB . 98.0 mttt 58.29 3.67 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.708 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.8 OUTLIER -138.5 117.15 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.517 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 18' ' ' CYS . 99.3 mttt -82.48 -11.7 58.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.537 ' HA3' ' CG ' ' A' ' 15' ' ' ASP . . . -106.62 -175.19 23.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.31 145.31 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.62 36.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -53.29 -38.33 81.81 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.863 2.375 . . . . 0.0 112.062 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.94 -170.05 32.2 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 79.02 11.49 85.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -47.85 -67.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 0.0 110.477 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.508 ' C ' ' HA ' ' A' ' 17' ' ' LYS . 6.5 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.625 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.432 ' CB ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -87.65 -83.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.878 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.579 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 5.6 pt -70.43 -42.58 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.094 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.547 ' N ' ' CG1' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.529 ' N ' HG13 ' A' ' 3' ' ' ILE . . . -124.11 -145.85 6.81 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.07 6.08 28.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.756 0.312 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.579 ' OG ' ' CD1' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -70.82 177.77 1.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.1 Cg_exo -53.89 -38.18 85.81 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.766 2.311 . . . . 0.0 112.014 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . 133.94 -110.56 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.601 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . -111.04 72.31 0.81 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 110.152 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 24.4 Cg_exo -50.71 142.33 32.39 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.678 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 58.6 t-20 -156.3 19.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.561 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 17' ' ' LYS . 4.5 p-10 -119.74 94.94 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.5 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 51.0 p90 32.52 28.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.13 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.629 ' N ' ' O ' ' A' ' 15' ' ' ASP . 83.0 mttt -152.35 24.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.678 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.1 OUTLIER -155.9 54.33 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.736 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.516 ' C ' ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' CYS . 99.0 mttt -136.27 153.19 51.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.85 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.16 157.17 8.32 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -125.99 135.39 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.69 -103.44 1.93 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.59 150.73 51.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.877 2.385 . . . . 0.0 112.132 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.71 47.25 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 167.19 99.38 0.13 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' TYR . 5.2 t -119.13 119.08 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 110.574 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 31.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.607 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -92.62 -57.88 2.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.139 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.681 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.2 mp -79.9 -4.96 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.052 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.681 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -126.9 -120.58 2.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.86 14.53 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.496 ' HB2' ' CD ' ' A' ' 8' ' ' PRO . 69.5 p -103.35 171.65 4.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.555 ' O ' ' O ' ' A' ' 9' ' ' GLY . 23.9 Cg_exo -62.09 146.66 96.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 123.017 2.478 . . . . 0.0 112.014 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -43.08 177.12 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.606 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . 177.37 72.49 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.223 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 14' ' ' ASN . 9.9 Cg_endo -53.09 137.33 62.61 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.874 2.383 . . . . 0.0 111.721 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.678 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.585 ' O ' ' CB ' ' A' ' 20' ' ' LYS . 25.8 t-20 -118.67 -1.8 11.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.532 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.583 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 62.8 m-20 -161.97 175.5 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.514 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 70.0 t80 72.45 -64.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 60.6 mttm -153.92 66.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 0.0 OUTLIER -151.35 47.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.533 ' H ' ' N ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 74.8 mmtt -126.04 145.37 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.86 112.01 1.12 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -66.54 -38.96 88.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.756 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.75 -135.0 5.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.577 ' O ' ' C ' ' A' ' 25' ' ' GLY . 36.8 Cg_endo -66.91 -19.49 52.27 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.87 2.38 . . . . 0.0 112.25 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 24' ' ' PRO . . . -19.48 130.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -78.6 175.89 54.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.706 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 5.9 t -109.16 177.65 4.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.662 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.706 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 18.1 p90 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.778 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.567 ' SG ' ' HG3' ' A' ' 8' ' ' PRO . 9.0 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.663 ' SG ' ' CD1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -95.6 -39.33 9.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.033 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.674 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.1 mp -101.21 -3.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.2 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.674 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -122.65 -110.3 2.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.4 tp10 -125.51 -13.25 6.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.9 0.381 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.556 ' O ' ' OG ' ' A' ' 7' ' ' SER . 6.1 p -145.57 73.68 13.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 31.9 Cg_exo -54.92 -149.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.904 2.402 . . . . 0.0 112.202 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.22 67.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.48 ' O ' HD13 ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 15' ' ' ASP . . . 60.47 54.65 3.71 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.718 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.2 Cg_endo -70.33 44.93 0.49 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.781 2.32 . . . . 0.0 112.074 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG ' ' A' ' 7' ' ' SER . 11.9 t30 -125.07 -13.1 6.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.022 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.588 ' OD1' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -156.81 66.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.599 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.559 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 4.1 t80 174.08 84.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.869 0.366 . . . . 0.0 110.491 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' H ' ' CZ ' ' A' ' 22' ' ' ARG . 97.4 mttt 53.46 7.89 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.333 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' H ' ' C ' ' A' ' 16' ' ' TYR . 38.3 m -65.78 -38.19 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.391 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.553 ' O ' ' C ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.629 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 60.5 tptt -107.24 159.7 16.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.484 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' OD1' ' A' ' 15' ' ' ASP . . . -57.06 161.94 7.74 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.601 ' HB2' ' CE2' ' A' ' 28' ' ' TYR . 38.9 mtm-85 -153.81 -164.12 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.719 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.88 -78.79 1.41 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -53.52 -38.83 83.79 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.86 2.373 . . . . 0.0 112.317 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' C ' ' HH ' ' A' ' 28' ' ' TYR . . . 147.82 152.39 5.67 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' N ' ' CZ ' ' A' ' 28' ' ' TYR . . . -173.35 -178.36 43.27 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 28' ' ' TYR . 15.4 p -62.16 -52.06 65.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' N ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 m-30 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.673 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -93.02 -45.58 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.593 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.669 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 3.7 tp -109.19 5.08 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.654 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.546 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -118.77 -128.72 3.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.5 tp10 -109.23 -10.66 14.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -84.4 165.84 36.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.61 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -53.69 -38.36 84.54 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.763 2.308 . . . . 0.0 112.023 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.659 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 174.59 -121.96 0.86 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.659 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.57 ' C ' ' O ' ' A' ' 10' ' ' DAL . . . 25.25 62.16 0.45 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.667 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 24.6 Cg_exo -53.11 -73.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.763 2.309 . . . . 0.0 112.158 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.581 ' CG ' ' C ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.564 ' HB3' ' CB ' ' A' ' 11' ' ' ALA . 12.5 t-20 -108.82 8.99 26.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.7 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.576 ' OD2' ' CG2' ' A' ' 3' ' ' ILE . 61.6 t0 -156.72 -87.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.378 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.641 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 22.8 t80 -68.57 130.73 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 9.0 ttmt 68.7 10.2 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.256 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -141.26 -20.7 0.77 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.623 ' CG ' ' O ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' DBB . 14.7 tttp 36.13 26.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.348 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' DBB . . . -126.92 156.03 20.02 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 62.5 ttp180 -61.61 -43.12 99.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.22 126.14 9.23 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.99 156.06 47.74 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.944 2.43 . . . . 0.0 112.39 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.33 145.08 18.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 63.72 27.58 71.3 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.562 ' HA ' ' N ' ' A' ' 19' ' ' DBB . 84.1 m -102.01 147.24 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.219 0.533 . . . . 0.0 111.18 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' CYS . 21.1 m-30 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.524 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.51 ' CB ' ' H ' ' A' ' 10' ' ' DAL . 0.1 OUTLIER -67.77 -83.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.615 ' O ' ' C ' ' A' ' 4' ' ' DBB . 10.7 tp -98.87 19.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.273 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.615 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.542 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -142.88 -164.94 10.4 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.52 -5.32 22.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -58.38 -175.51 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 45.7 Cg_exo -53.27 -38.08 81.44 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.746 2.298 . . . . 0.0 111.896 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.639 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 103.5 164.83 25.38 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.639 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -113.95 71.89 2.06 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.862 0.363 . . . . 0.0 110.176 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 13' ' ' DBB . 18.5 Cg_endo -60.38 147.33 94.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.608 2.205 . . . . 0.0 111.009 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.58 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.588 ' OD1' ' CE ' ' A' ' 20' ' ' LYS . 2.0 t-20 -136.71 43.19 2.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.488 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.623 ' O ' ' C ' ' A' ' 16' ' ' TYR . 67.6 t0 176.92 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.623 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 9.25 -82.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.266 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ASP . 68.5 mttm -138.63 29.61 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.455 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.665 ' C ' ' SG ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER -102.28 -68.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.585 ' O ' ' HG3' ' A' ' 20' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' CE ' ' OD1' ' A' ' 14' ' ' ASN . 16.6 mttm 163.33 -94.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.55 125.35 2.79 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' CG ' ' HA3' ' A' ' 5' ' ' GLY . 62.2 ttp180 -63.41 -43.06 98.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.741 0.305 . . . . 0.0 110.692 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.68 -120.68 1.65 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.32 -38.7 82.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.717 2.278 . . . . 0.0 112.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.31 126.28 1.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' TYR . . . -133.63 -68.89 0.08 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.719 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 43.3 t -66.43 -111.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.719 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p90 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.636 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.638 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -79.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.419 . . . . 0.0 109.934 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.541 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 1.2 mp -65.28 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.901 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.71 -108.23 1.1 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.3 tp10 -106.37 -11.32 16.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 110.604 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.516 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 1.3 m -60.92 125.8 84.23 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -53.51 -39.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.859 2.373 . . . . 0.0 112.141 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -179.75 -166.31 35.16 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' DAL . . . . . 0.663 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . 43.51 59.97 11.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.042 0.448 . . . . 0.0 110.533 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' C ' ' N ' ' A' ' 14' ' ' ASN . 11.8 Cg_endo -58.21 137.6 81.5 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.792 2.328 . . . . 0.0 111.817 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.725 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' N ' ' C ' ' A' ' 12' ' ' PRO . 66.2 t30 -137.14 15.83 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.451 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.666 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 30.2 t0 175.07 173.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.78 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.666 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 16.9 p90 48.71 11.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 51.3 mttt 150.33 45.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.437 0.46 . . . . 0.0 110.532 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.725 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 1.1 m -171.53 88.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' DBB . . . . . 0.534 ' C ' ' HG3' ' A' ' 20' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.9 mttt -158.33 152.75 24.42 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.669 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.574 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -158.34 -142.52 3.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -61.12 -42.44 98.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.653 0.263 . . . . 0.0 110.54 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.94 -71.16 0.1 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.54 -20.25 47.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.872 2.381 . . . . 0.0 112.105 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 21' ' ' GLY . . . -168.11 -141.14 3.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 21' ' ' GLY . . . 86.66 13.65 66.95 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.551 ' SG ' ' HD1' ' A' ' 28' ' ' TYR . 1.7 t -87.24 130.8 34.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 110.643 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.551 ' HD1' ' SG ' ' A' ' 27' ' ' CYS . 12.5 m-85 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.492 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -67.07 -46.65 73.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 110.002 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.592 ' CD1' ' CB ' ' A' ' 7' ' ' SER . 50.3 pt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.198 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.1 10.75 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.598 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -86.88 -175.04 0.54 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.1 Cg_exo -52.63 -38.38 75.99 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.745 2.297 . . . . 0.0 112.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.612 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.073 0.463 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 C--N 1.304 -1.785 0 C-N-CA 123.008 2.472 . . . . 0.0 111.417 179.708 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.522 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.2 t-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.865 0.364 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 11' ' ' ALA . 53.7 p-10 -135.78 -147.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.551 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . 15.7 p90 -76.28 34.11 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.211 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 27' ' ' CYS . 67.6 mttm -153.44 18.18 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.947 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 27' ' ' CYS . 3.5 m . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.7 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 118.8 -158.3 14.88 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -128.98 147.84 50.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.08 143.53 4.07 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.54 -38.34 83.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.811 2.341 . . . . 0.0 112.001 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.55 -163.11 10.1 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 16' ' ' TYR . . . 69.27 105.31 0.03 OUTLIER Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 18' ' ' CYS . 8.6 t . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.857 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HG ' ' N ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -59.42 -41.29 89.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.601 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 10.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.267 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.407 ' N ' ' HG ' ' A' ' 1' ' ' CYS . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 81.3 tt0 -88.2 -9.97 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 0.0 110.377 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER 57.39 52.17 5.5 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 7' ' ' SER . 34.1 Cg_endo -66.73 -20.29 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.818 2.345 . . . . 0.0 112.128 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.025 0.44 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.1 Cg_endo . . . . . 0 C--N 1.304 -1.802 0 C-N-CA 123.009 2.473 . . . . 0.0 111.692 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' O ' ' A' ' 20' ' ' LYS . 9.6 t30 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.69 0.281 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.582 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 27.5 t0 -162.03 176.1 11.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.857 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HD2' ' HB2' ' A' ' 17' ' ' LYS . 60.3 t80 54.25 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.866 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.58 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 8.7 ttmt -111.87 62.83 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.742 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' O ' ' N ' ' A' ' 20' ' ' LYS . 1.3 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' CYS . 75.7 mmtt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.763 0.316 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.43 95.17 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.553 ' O ' ' O ' ' A' ' 23' ' ' GLY . 72.8 ttp85 -63.57 -42.91 98.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -54.08 -129.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.16 -38.17 80.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.794 2.329 . . . . 0.0 112.22 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 -142.51 17.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.23 161.58 36.68 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 18' ' ' CYS . 5.5 t . . . . . 0 C--N 1.329 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.588 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.524 ' HB3' HD12 ' A' ' 3' ' ' ILE . 53.7 t -47.39 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.119 HD11 ' O ' ' A' ' 9' ' ' GLY . 3.6 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 97.9 mt-10 -135.32 16.6 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.652 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.57 176.51 2.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.645 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 46.1 Cg_exo -53.11 -39.49 79.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.828 2.352 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 1.119 ' O ' HD11 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 C-N-CA 123.023 2.482 . . . . 0.0 111.847 179.583 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.561 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.4 t-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.706 0.289 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.642 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 52.4 p-10 -128.92 -140.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.956 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 52.3 p90 -37.13 139.16 0.24 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.451 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 98.6 mttt 49.15 14.28 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.467 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 56.2 mtmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.13 -167.85 11.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 7' ' ' SER . 24.8 tpt180 -115.2 132.05 56.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 6' ' ' GLU . . . 125.26 153.77 8.59 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.55 155.79 54.5 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.914 2.409 . . . . 0.0 112.102 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . 118.47 170.2 14.79 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 25' ' ' GLY . . . -26.88 89.75 0.01 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 1.7 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.825 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 t -79.86 131.35 35.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.589 HG13 ' CE2' ' A' ' 16' ' ' TYR . 1.1 mp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.885 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.714 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 7' ' ' SER . 19.6 pt-20 -105.47 -6.61 19.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 9.9 p -38.2 154.36 0.13 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 -20.8 55.15 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.822 2.348 . . . . 0.0 111.957 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.953 0.406 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 C--N 1.3 -2.001 0 C-N-CA 122.395 2.063 . . . . 0.0 111.508 179.637 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.742 ' N ' ' HG ' ' A' ' 18' ' ' CYS . 23.1 t-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 7' ' ' SER . 11.4 t70 -138.88 -46.23 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 52.0 p90 -135.93 137.53 41.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 26' ' ' GLY . 57.8 mtpt 61.61 29.17 18.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.742 ' HG ' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.442 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 68.9 mttm . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.776 0.322 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 15' ' ' ASP . . . -98.29 151.89 19.7 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 89.0 mtm180 -64.56 -39.25 93.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.559 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.04 106.09 0.42 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 36.7 Cg_endo -67.99 -17.91 46.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.845 2.364 . . . . 0.0 112.188 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.6 95.98 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 17' ' ' LYS . . . -120.32 109.83 1.66 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.82 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.642 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -81.96 -47.5 12.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 110.369 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.683 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.183 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.47 ' N ' HG23 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.564 ' OE2' ' O ' ' A' ' 22' ' ' ARG . 17.2 pt-20 -108.95 -8.2 15.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 8' ' ' PRO . 24.4 m -120.15 72.29 18.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.683 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 7' ' ' SER . 48.8 Cg_exo -50.72 -145.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.866 2.377 . . . . 0.0 112.439 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.599 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 11' ' ' ALA . 22.4 Cg_exo . . . . . 0 C--N 1.305 -1.749 0 C-N-CA 123.101 2.534 . . . . 0.0 111.733 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 20' ' ' LYS . 54.4 t30 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 3.1 m-20 -157.43 169.57 24.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.566 ' HB2' ' CG1' ' A' ' 3' ' ' ILE . 65.2 t80 77.45 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.704 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.569 ' O ' ' O ' ' A' ' 27' ' ' CYS . 72.5 tttt -118.95 33.28 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.53 ' C ' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 14' ' ' ASN . 64.5 mttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.537 ' HA2' ' OD2' ' A' ' 15' ' ' ASP . . . 125.97 163.17 11.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.564 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mtt-85 -128.13 149.29 50.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.688 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.85 -106.86 1.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -54.34 -34.71 81.54 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.11 10.83 70.87 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -62.83 148.93 49.67 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.6 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.69 0.281 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.994 HD12 ' CB ' ' A' ' 7' ' ' SER . 67.0 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.799 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 83.6 tt0 -113.65 -7.28 13.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.994 ' CB ' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -56.13 145.25 56.53 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.26 -21.17 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.885 2.39 . . . . 0.0 112.096 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.616 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.1 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 C-N-CA 122.789 2.326 . . . . 0.0 111.723 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 12' ' ' PRO . 7.7 t-20 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.595 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 32.5 m-20 -142.03 145.1 34.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 3.7 t80 87.63 87.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 99.5 mttt 68.13 -8.82 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.709 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.599 ' HG ' ' N ' ' A' ' 14' ' ' ASN . 96.8 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.365 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 23.5 tptm . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.847 0.356 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.522 ' HA2' ' OD1' ' A' ' 15' ' ' ASP . . . -59.62 136.8 50.21 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 78.3 ttt-85 -133.85 125.86 29.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.67 -71.04 0.22 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 55.3 Cg_endo -73.02 160.57 45.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.89 2.393 . . . . 0.0 112.17 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.22 140.59 44.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.58 -171.14 29.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.0 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.525 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.734 ' HG ' ' N ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.0 m -60.03 -46.08 90.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.696 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.03 HD12 ' CB ' ' A' ' 7' ' ' SER . 96.6 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.169 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.734 ' N ' ' HG ' ' A' ' 1' ' ' CYS . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HB3' ' HD3' ' A' ' 24' ' ' PRO . 76.4 mm-40 -116.27 -4.56 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.817 0.341 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 1.03 ' CB ' HD12 ' A' ' 3' ' ' ILE . 1.3 m -142.33 166.45 21.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 29.3 Cg_endo -64.77 -21.85 64.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.95 2.433 . . . . 0.0 111.77 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 11.3 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 C-N-CA 122.761 2.307 . . . . 0.0 111.786 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.883 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 48.4 t30 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.617 0.246 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 78.6 m-20 -155.19 -84.77 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 111.168 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.644 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 17.6 t80 -69.29 135.5 50.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.921 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.508 ' HE3' ' CE2' ' A' ' 16' ' ' TYR . 98.1 mttt 68.75 18.88 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.425 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 14' ' ' ASN . 64.4 mttp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 15' ' ' ASP . . . -66.34 81.28 0.11 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 23' ' ' GLY . 79.6 mtp85 -65.3 -37.63 87.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -53.06 -134.61 0.0 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -52.87 -39.18 78.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.719 2.279 . . . . 0.0 112.231 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.69 -120.73 1.09 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' LYS . . . 71.06 63.92 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' CYS . 6.3 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.539 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 1.6 t -78.38 -74.07 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.612 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.746 HG21 ' HB3' ' A' ' 11' ' ' ALA . 11.3 tp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.352 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.541 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.88 4.56 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.607 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -166.88 -67.0 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.722 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.66 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 54.1 Cg_endo -70.43 151.02 65.0 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.767 2.311 . . . . 0.0 112.199 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.539 ' C ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 14' ' ' ASN . 38.3 Cg_exo . . . . . 0 C--N 1.3 -2.0 0 C-N-CA 122.664 2.243 . . . . 0.0 110.972 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.79 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 22.1 t-20 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.884 0.373 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.543 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 87.0 m-20 -143.16 155.66 44.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.78 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER 81.33 79.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.483 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 63.8 mttp 68.35 -5.18 0.95 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.754 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' H ' ' C ' ' A' ' 16' ' ' TYR . 93.2 m . . . . . 0 C--N 1.332 -0.174 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.79 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 14' ' ' ASN . 7.6 tttm . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.669 0.271 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 27' ' ' CYS . . . -163.28 138.45 5.33 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -81.7 -20.54 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.835 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -42.88 144.15 1.26 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.25 -25.04 64.89 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.856 2.37 . . . . 0.0 112.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 26' ' ' GLY . . . -96.82 146.36 18.25 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 25' ' ' GLY . . . 35.24 -160.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.593 ' O ' ' O ' ' A' ' 21' ' ' GLY . 97.6 m . . . . . 0 C--N 1.326 -0.416 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.424 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -87.74 -45.28 10.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.011 HD13 ' OD2' ' A' ' 15' ' ' ASP . 3.0 tt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.295 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.0 tp10 -107.72 -10.05 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.225 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -74.44 154.06 87.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.577 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.31 -20.79 55.17 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.814 2.342 . . . . 0.0 112.062 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.586 2.191 . . . . 0.0 111.578 179.841 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.614 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 66.3 t30 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.737 0.303 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 1.011 ' OD2' HD13 ' A' ' 3' ' ' ILE . 64.5 t0 -142.52 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.669 ' HB2' HD11 ' A' ' 3' ' ' ILE . 23.4 t80 -80.05 131.29 35.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 15.4 tttp 78.84 1.49 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' C ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.326 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 14' ' ' ASN . . . -68.04 -42.8 83.97 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 55.52 79.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.62 -163.4 11.83 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.91 -21.54 57.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.895 2.397 . . . . 0.0 112.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.9 -156.19 7.45 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . 62.94 -130.47 42.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HA ' ' C ' ' A' ' 18' ' ' CYS . 14.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.1 m -88.81 -74.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.56 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.328 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -93.61 -66.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.307 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 155.8 -64.15 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.76 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 35.3 Cg_endo -67.26 -17.38 49.91 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.967 2.444 . . . . 0.0 112.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.424 ' N ' ' OE1' ' A' ' 6' ' ' GLU . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.779 0.323 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 14' ' ' ASN . 15.3 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' N ' ' HG ' ' A' ' 18' ' ' CYS . 47.6 t30 . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.582 ' OD1' ' CA ' ' A' ' 21' ' ' GLY . 31.2 t70 -155.08 -86.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.645 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 56.8 t80 -70.96 131.48 43.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 26' ' ' GLY . 23.4 mtpt 61.43 33.14 18.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.046 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.582 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.825 0.345 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -96.82 120.79 6.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' GLY . 90.1 mtm180 -96.87 0.63 49.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -55.69 -152.74 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.45 -39.32 82.43 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.839 2.359 . . . . 0.0 112.153 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.79 -167.84 38.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.597 ' HA3' ' CD1' ' A' ' 16' ' ' TYR . . . 99.81 103.67 2.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.466 ' C ' ' HA ' ' A' ' 17' ' ' LYS . 7.6 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 110.665 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -79.8 -46.03 17.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.333 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.561 HD12 ' CD1' ' A' ' 16' ' ' TYR . 4.2 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.488 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -100.83 -5.93 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.06 0.457 . . . . 0.0 110.1 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -72.11 176.4 2.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.377 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 9' ' ' GLY . 56.1 Cg_endo -71.77 159.23 51.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.66 2.24 . . . . 0.0 111.88 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ASN . 32.9 Cg_exo . . . . . 0 C--N 1.301 -1.93 0 C-N-CA 122.54 2.16 . . . . 0.0 111.036 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' PRO . 35.6 t30 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.799 0.333 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' A' ' 16' ' ' TYR . 54.0 p-10 -150.2 -136.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.561 ' CD1' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER 26.68 -93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.592 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ASP . 56.5 mtmt -130.09 76.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.782 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.909 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.75 0.309 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.99 171.45 16.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -131.62 146.36 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.48 151.73 8.3 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.99 144.81 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.977 2.451 . . . . 0.0 112.1 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.79 152.9 22.77 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.77 -172.59 14.47 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 8' ' ' PRO . 10.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.4 -37.69 10.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.173 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.86 HD11 ' HB2' ' A' ' 11' ' ' ALA . 40.0 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.963 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.26 -5.49 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.648 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -173.13 80.69 0.41 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.341 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 12.1 Cg_endo -56.53 -41.46 75.8 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 112.212 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.86 ' HB2' HD11 ' A' ' 3' ' ' ILE . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 C-N-CA 122.888 2.392 . . . . 0.0 111.747 179.839 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' OD1' ' CB ' ' A' ' 20' ' ' LYS . 65.0 t30 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.544 0.211 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.69 ' OD2' HG23 ' A' ' 3' ' ' ILE . 63.8 t0 -141.52 -107.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.137 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 18' ' ' CYS . 39.7 p90 -53.94 144.67 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.772 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.557 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 99.0 mttt 32.61 30.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.594 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' TYR . 1.1 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.663 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 57.8 mtpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.802 0.334 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.92 173.09 42.83 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -112.28 131.65 55.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.7 -118.6 0.88 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 25' ' ' GLY . 59.9 Cg_endo -73.2 157.4 50.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.823 2.349 . . . . 0.0 112.183 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 24' ' ' PRO . . . -51.52 -162.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 17' ' ' LYS . . . 82.27 20.34 62.74 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.432 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.646 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.605 ' O ' HG22 ' A' ' 3' ' ' ILE . 2.7 t -79.01 134.48 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.654 HG23 ' O ' ' A' ' 3' ' ' ILE . 1.8 tp . . . . . 0 C--N 1.331 -0.207 0 O-C-N 123.309 0.381 . . . . 0.0 110.246 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.582 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -103.86 -5.01 22.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 110.52 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.13 172.79 1.72 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -53.39 -38.18 82.38 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.866 2.377 . . . . 0.0 112.182 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.794 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.996 0.426 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo . . . . . 0 C--N 1.301 -1.949 0 C-N-CA 122.718 2.279 . . . . 0.0 111.782 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.794 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 61.4 t-20 . . . . . 0 C--O 1.228 -0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.615 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 98.7 m-20 -118.69 155.4 31.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.609 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.615 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 92.56 11.58 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.772 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 56.8 mttp 88.21 39.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.42 0.45 . . . . 0.0 110.905 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 179.77 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 14' ' ' ASN . 57.8 mtpt . . . . . 0 N--CA 1.46 0.048 0 CA-C-O 120.901 0.381 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.89 149.35 5.33 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -94.67 -5.44 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.781 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.87 159.85 42.35 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.69 143.72 47.13 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.906 2.404 . . . . 0.0 111.979 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.06 -174.97 19.83 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.638 ' O ' ' SG ' ' A' ' 27' ' ' CYS . . . 65.59 28.45 73.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.638 ' SG ' ' O ' ' A' ' 26' ' ' GLY . 2.1 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.549 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.1 m -63.44 -45.07 92.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.224 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.744 HD12 ' OG ' ' A' ' 7' ' ' SER . 85.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.381 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -108.8 -4.15 17.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.369 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.744 ' OG ' HD12 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -143.75 -175.48 0.48 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.763 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.4 Cg_exo -52.4 -38.2 73.35 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.991 2.46 . . . . 0.0 112.064 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.888 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.711 ' HB3' HD11 ' A' ' 3' ' ' ILE . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.095 0.474 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo . . . . . 0 C--N 1.301 -1.929 0 C-N-CA 122.849 2.366 . . . . 0.0 111.915 179.682 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.69 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 63.6 t30 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.74 ' HB2' HD13 ' A' ' 3' ' ' ILE . 1.0 OUTLIER 68.88 -76.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.794 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 25.0 t80 -70.88 126.47 29.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HE3' ' CE2' ' A' ' 16' ' ' TYR . 98.0 mttt 58.29 3.67 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.552 ' HA3' ' CG ' ' A' ' 15' ' ' ASP . . . -106.62 -175.19 23.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.31 145.31 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.62 36.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -53.29 -38.33 81.81 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.863 2.375 . . . . 0.0 112.062 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.94 -170.05 32.2 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 79.02 11.49 85.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 0.0 110.477 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.432 ' CB ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -87.65 -83.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.878 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.612 HG22 ' HB3' ' A' ' 15' ' ' ASP . 5.6 pt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.094 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.07 6.08 28.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.756 0.312 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.579 ' OG ' ' CD1' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -70.82 177.77 1.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 7' ' ' SER . 47.1 Cg_exo -53.89 -38.18 85.81 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.766 2.311 . . . . 0.0 112.014 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.304 -1.793 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.66 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 58.6 t-20 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.702 0.287 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 17' ' ' LYS . 4.5 p-10 -119.74 94.94 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 51.0 p90 32.52 28.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.13 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.629 ' N ' ' O ' ' A' ' 15' ' ' ASP . 83.0 mttt -152.35 24.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.736 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' CYS . 99.0 mttt . . . . . 0 CA--C 1.526 0.054 0 CA-C-O 120.793 0.33 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.16 157.17 8.32 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -125.99 135.39 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.69 -103.44 1.93 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.59 150.73 51.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.877 2.385 . . . . 0.0 112.132 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.71 47.25 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 167.19 99.38 0.13 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 110.574 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -92.62 -57.88 2.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.139 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.55 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.052 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.86 14.53 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 69.5 p -103.35 171.65 4.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.555 ' O ' ' O ' ' A' ' 9' ' ' GLY . 23.9 Cg_exo -62.09 146.66 96.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 123.017 2.478 . . . . 0.0 112.014 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.874 2.383 . . . . 0.0 111.721 179.689 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.792 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 25.8 t-20 . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.641 0.258 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.583 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 62.8 m-20 -161.97 175.5 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 70.0 t80 72.45 -64.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 16' ' ' TYR . 60.6 mttm -153.92 66.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.562 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 74.8 mmtt . . . . . 0 N--CA 1.46 0.068 0 CA-C-O 120.929 0.395 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.86 112.01 1.12 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 8' ' ' PRO . 83.9 mtt85 -66.54 -38.96 88.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.756 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 24' ' ' PRO . . . -88.75 -135.0 5.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.577 ' O ' ' C ' ' A' ' 25' ' ' GLY . 36.8 Cg_endo -66.91 -19.49 52.27 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.87 2.38 . . . . 0.0 112.25 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 24' ' ' PRO . . . -19.48 130.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -78.6 175.89 54.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 17' ' ' LYS . 5.9 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.584 ' SG ' ' HG3' ' A' ' 8' ' ' PRO . 9.0 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.971 ' SG ' HD13 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -95.6 -39.33 9.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.033 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.971 HD13 ' SG ' ' A' ' 2' ' ' CYS . 1.1 mp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.2 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.4 tp10 -125.51 -13.25 6.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.9 0.381 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.556 ' O ' ' OG ' ' A' ' 7' ' ' SER . 6.1 p -145.57 73.68 13.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 31.9 Cg_exo -54.92 -149.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.904 2.402 . . . . 0.0 112.202 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.879 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 15' ' ' ASP . . . . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 121.011 0.434 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.2 Cg_endo . . . . . 0 C--N 1.304 -1.806 0 C-N-CA 122.781 2.32 . . . . 0.0 112.074 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 2.2 t-20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.701 0.286 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.588 ' OD1' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -156.81 66.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.599 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.563 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 4.1 t80 174.08 84.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.869 0.366 . . . . 0.0 110.491 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.542 ' H ' ' CZ ' ' A' ' 22' ' ' ARG . 97.4 mttt 53.46 7.89 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.333 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' TYR . 38.3 m . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HG3' ' N ' ' A' ' 21' ' ' GLY . 60.5 tptt . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' OD1' ' A' ' 15' ' ' ASP . . . -57.06 161.94 7.74 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.588 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 38.9 mtm-85 -153.81 -164.12 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.719 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.88 -78.79 1.41 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -53.52 -38.83 83.79 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.86 2.373 . . . . 0.0 112.317 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.82 152.39 5.67 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.477 ' HA3' ' HE ' ' A' ' 22' ' ' ARG . . . -173.35 -178.36 43.27 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 110.765 -179.893 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -93.02 -45.58 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.593 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.882 HD11 ' HB2' ' A' ' 16' ' ' TYR . 3.7 tp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.5 tp10 -109.23 -10.66 14.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.4 m -84.4 165.84 36.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.61 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 7' ' ' SER . 46.4 Cg_exo -53.69 -38.36 84.54 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.763 2.308 . . . . 0.0 112.023 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.897 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.667 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 24.6 Cg_exo . . . . . 0 C--N 1.301 -1.945 0 C-N-CA 122.763 2.309 . . . . 0.0 112.158 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.912 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 12.5 t-20 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.629 0.252 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.576 ' OD2' ' CG2' ' A' ' 3' ' ' ILE . 61.6 t0 -156.72 -87.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.378 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.882 ' HB2' HD11 ' A' ' 3' ' ' ILE . 22.8 t80 -68.57 130.73 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt 68.7 10.2 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.256 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.7 tttp . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.783 0.325 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.92 156.03 20.02 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 62.5 ttp180 -61.61 -43.12 99.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.22 126.14 9.23 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.99 156.06 47.74 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.944 2.43 . . . . 0.0 112.39 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.33 145.08 18.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 63.72 27.58 71.3 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.219 0.533 . . . . 0.0 111.18 -179.421 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -83.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.528 HG12 ' OD2' ' A' ' 15' ' ' ASP . 10.7 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.273 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.522 ' HA3' ' CG ' ' A' ' 22' ' ' ARG . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.52 -5.32 22.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -58.38 -175.51 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 45.7 Cg_exo -53.27 -38.08 81.44 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.746 2.298 . . . . 0.0 111.896 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.649 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.411 ' C ' ' N ' ' A' ' 14' ' ' ASN . 18.5 Cg_endo . . . . . 0 C--N 1.306 -1.692 0 C-N-CA 122.608 2.205 . . . . 0.0 111.009 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.851 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 2.0 t-20 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.761 0.315 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.623 ' O ' ' C ' ' A' ' 16' ' ' TYR . 67.6 t0 176.92 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.623 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 9.25 -82.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.266 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ASP . 68.5 mttm -138.63 29.61 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.455 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' CE ' ' OD1' ' A' ' 14' ' ' ASN . 16.6 mttm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.968 0.413 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.55 125.35 2.79 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.522 ' CG ' ' HA3' ' A' ' 5' ' ' GLY . 62.2 ttp180 -63.41 -43.06 98.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.741 0.305 . . . . 0.0 110.692 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.68 -120.68 1.65 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.32 -38.7 82.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.717 2.278 . . . . 0.0 112.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.31 126.28 1.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' TYR . . . -133.63 -68.89 0.08 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.667 ' SG ' ' C ' ' A' ' 18' ' ' CYS . 43.3 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.638 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -79.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.419 . . . . 0.0 109.934 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.541 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.901 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.3 tp10 -106.37 -11.32 16.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 110.604 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.521 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 1.3 m -60.92 125.8 84.23 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -53.51 -39.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.859 2.373 . . . . 0.0 112.141 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.042 0.448 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.563 ' C ' ' N ' ' A' ' 14' ' ' ASN . 11.8 Cg_endo . . . . . 0 C--N 1.301 -1.931 0 C-N-CA 122.792 2.328 . . . . 0.0 111.817 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.563 ' N ' ' C ' ' A' ' 12' ' ' PRO . 66.2 t30 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.666 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 30.2 t0 175.07 173.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.78 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.666 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 16.9 p90 48.71 11.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 51.3 mttt 150.33 45.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.437 0.46 . . . . 0.0 110.532 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 20' ' ' LYS . 1.1 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.9 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.574 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -158.34 -142.52 3.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -61.12 -42.44 98.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.653 0.263 . . . . 0.0 110.54 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.94 -71.16 0.1 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.54 -20.25 47.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.872 2.381 . . . . 0.0 112.105 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 21' ' ' GLY . . . -168.11 -141.14 3.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 21' ' ' GLY . . . 86.66 13.65 66.95 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 110.643 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.492 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -67.07 -46.65 73.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 110.002 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.629 ' O ' ' C ' ' A' ' 4' ' ' DBB . 50.3 pt -130.29 3.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.198 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.629 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -133.57 -127.87 2.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.806 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.1 10.75 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.598 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -86.88 -175.04 0.54 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.1 Cg_exo -52.63 -38.38 75.99 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.745 2.297 . . . . 0.0 112.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 134.08 -124.58 3.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.674 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . 26.53 69.24 0.45 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.566 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.57 ' O ' ' HB3' ' A' ' 13' ' ' DBB . 29.5 Cg_endo -65.97 -13.43 39.79 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.008 2.472 . . . . 0.0 111.417 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.571 ' O ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.2 t-20 -135.69 35.84 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.781 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.569 ' OD1' ' CG ' ' A' ' 13' ' ' DBB . 53.7 p-10 -135.78 -147.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.551 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . 15.7 p90 -76.28 34.11 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.211 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 27' ' ' CYS . 67.6 mttm -153.44 18.18 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.947 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 27' ' ' CYS . 3.5 m -155.35 34.96 0.37 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.564 ' C ' ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.7 mttt -139.9 148.63 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.641 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 118.8 -158.3 14.88 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -128.98 147.84 50.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.08 143.53 4.07 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.54 -38.34 83.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.811 2.341 . . . . 0.0 112.001 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.55 -163.11 10.1 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 16' ' ' TYR . . . 69.27 105.31 0.03 OUTLIER Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' SG ' ' CE1' ' A' ' 28' ' ' TYR . 8.6 t -128.73 -72.62 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.707 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 98.8 m-85 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.554 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -59.42 -41.29 89.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.61 HD13 ' O ' ' A' ' 10' ' ' DAL . 10.0 tp -109.91 2.75 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.267 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.91 -122.44 2.76 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 81.3 tt0 -88.2 -9.97 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 0.0 110.377 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER 57.39 52.17 5.5 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 7' ' ' SER . 34.1 Cg_endo -66.73 -20.29 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.818 2.345 . . . . 0.0 112.128 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . 166.46 55.78 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.61 ' O ' HD13 ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . . . 62.45 57.58 2.55 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.513 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.66 ' O ' ' HG2' ' A' ' 13' ' ' DBB . 37.1 Cg_endo -69.26 -10.22 28.39 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.009 2.473 . . . . 0.0 111.692 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.66 ' HG2' ' O ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' O ' ' A' ' 20' ' ' LYS . 9.6 t30 -122.37 -1.72 9.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.676 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.632 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 27.5 t0 -162.03 176.1 11.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.857 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HD2' ' HB2' ' A' ' 17' ' ' LYS . 60.3 t80 54.25 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.866 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.58 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 8.7 ttmt -111.87 62.83 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.742 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.632 ' SG ' ' O ' ' A' ' 15' ' ' ASP . 1.3 m -155.92 139.32 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.644 ' H1 ' ' H ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' CYS . 75.7 mmtt -116.14 119.57 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.43 95.17 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.553 ' O ' ' O ' ' A' ' 23' ' ' GLY . 72.8 ttp85 -63.57 -42.91 98.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -54.08 -129.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.16 -38.17 80.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.794 2.329 . . . . 0.0 112.22 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 -142.51 17.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.23 161.58 36.68 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 5.5 t -124.63 170.59 10.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.588 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.676 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 38.9 p90 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.694 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 10' ' ' DAL . 53.7 t -47.39 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.119 HD11 ' O ' ' A' ' 9' ' ' GLY . 3.6 mp -90.57 -39.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.16 22.08 79.23 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 97.9 mt-10 -135.32 16.6 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.652 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.57 176.51 2.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.645 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 46.1 Cg_exo -53.11 -39.49 79.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.828 2.352 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 1.119 ' O ' HD11 ' A' ' 3' ' ' ILE . . . 146.15 -160.68 28.21 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.71 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . 37.82 71.49 1.02 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.536 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.69 ' C ' ' HG2' ' A' ' 13' ' ' DBB . 19.2 Cg_endo -60.2 -18.77 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.023 2.482 . . . . 0.0 111.847 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.69 ' HG2' ' C ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.561 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.4 t-20 -118.26 13.83 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.523 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.822 ' HA ' ' HG2' ' A' ' 19' ' ' DBB . 52.4 p-10 -128.92 -140.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.956 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 52.3 p90 -37.13 139.16 0.24 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 98.6 mttt 49.15 14.28 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.666 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 0.7 OUTLIER -137.42 -16.08 1.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.467 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.822 ' HG2' ' HA ' ' A' ' 15' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 56.2 mtmt 66.0 20.05 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.381 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' N ' ' HG3' ' A' ' 19' ' ' DBB . . . -139.13 -167.85 11.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 7' ' ' SER . 24.8 tpt180 -115.2 132.05 56.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 6' ' ' GLU . . . 125.26 153.77 8.59 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.55 155.79 54.5 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.914 2.409 . . . . 0.0 112.102 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . 118.47 170.2 14.79 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 25' ' ' GLY . . . -26.88 89.75 0.01 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 1.7 t -149.07 155.56 40.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.825 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CG ' ' C ' ' A' ' 27' ' ' CYS . 6.1 m-85 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.479 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 4' ' ' DBB . 2.7 t -79.86 131.35 35.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.153 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.606 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.1 mp 63.05 0.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.885 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.606 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -129.86 -144.18 5.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 7' ' ' SER . 19.6 pt-20 -105.47 -6.61 19.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 9.9 p -38.2 154.36 0.13 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 -20.8 55.15 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.822 2.348 . . . . 0.0 111.957 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 10' ' ' DAL . . . 172.35 -168.39 41.46 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.643 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . -111.36 71.87 0.88 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.157 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 35.5 Cg_exo -48.54 135.32 26.93 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.395 2.063 . . . . 0.0 111.508 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.539 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 23.1 t-20 -148.59 13.4 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.565 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 7' ' ' SER . 11.4 t70 -138.88 -46.23 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 52.0 p90 -135.93 137.53 41.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 57.8 mtpt 61.61 29.17 18.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -130.89 -22.53 2.6 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.442 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.589 ' CG ' ' O ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 68.9 mttm -95.37 -8.3 36.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.448 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 15' ' ' ASP . . . -98.29 151.89 19.7 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 89.0 mtm180 -64.56 -39.25 93.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.559 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.04 106.09 0.42 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 36.7 Cg_endo -67.99 -17.91 46.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.845 2.364 . . . . 0.0 112.188 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.6 95.98 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 17' ' ' LYS . . . -120.32 109.83 1.66 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.721 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 35.0 t -137.23 125.79 23.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.82 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.721 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.11 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.642 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -81.96 -47.5 12.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 110.369 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.683 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 11.1 tp -97.22 -5.18 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.183 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.506 ' HG1' ' HB2' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' H ' HG23 ' A' ' 3' ' ' ILE . . . -123.89 -148.64 7.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.564 ' OE2' ' O ' ' A' ' 22' ' ' ARG . 17.2 pt-20 -108.95 -8.2 15.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 8' ' ' PRO . 24.4 m -120.15 72.29 18.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.683 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 7' ' ' SER . 48.8 Cg_exo -50.72 -145.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.866 2.377 . . . . 0.0 112.439 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.32 16.8 70.6 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.575 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.599 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . 25.86 58.12 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.822 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.68 ' O ' ' HG2' ' A' ' 13' ' ' DBB . 22.4 Cg_exo -60.9 -3.4 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.101 2.534 . . . . 0.0 111.733 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.68 ' HG2' ' O ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 20' ' ' LYS . 54.4 t30 -118.53 -11.97 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.764 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 3.1 m-20 -157.43 169.57 24.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.566 ' HB2' ' CG1' ' A' ' 3' ' ' ILE . 65.2 t80 77.45 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.704 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.569 ' O ' ' O ' ' A' ' 27' ' ' CYS . 72.5 tttt -118.95 33.28 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.8 OUTLIER -120.85 147.01 45.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.785 ' H1 ' ' H ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 14' ' ' ASN . 64.5 mttp -110.01 149.92 29.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.537 ' HA2' ' OD2' ' A' ' 15' ' ' ASP . . . 125.97 163.17 11.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.564 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mtt-85 -128.13 149.29 50.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.688 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.85 -106.86 1.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -54.34 -34.71 81.54 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.11 10.83 70.87 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -62.83 148.93 49.67 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' O ' ' C ' ' A' ' 28' ' ' TYR . 9.6 t -124.3 165.69 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.69 0.281 . . . . 0.0 110.53 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.785 ' H ' ' H1 ' ' A' ' 19' ' ' DBB . 99.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.812 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.994 HD12 ' CB ' ' A' ' 7' ' ' SER . 67.0 mt -65.55 -42.83 93.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.799 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.516 ' HG1' ' HB2' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.42 -110.45 1.53 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 83.6 tt0 -113.65 -7.28 13.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.994 ' CB ' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -56.13 145.25 56.53 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.26 -21.17 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.885 2.39 . . . . 0.0 112.096 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.658 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 156.34 -158.55 28.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.658 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . 38.1 66.96 2.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.593 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.616 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.1 Cg_endo -58.02 127.11 23.77 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.789 2.326 . . . . 0.0 111.723 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.62 ' C ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 12' ' ' PRO . 7.7 t-20 -103.5 -40.42 6.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.597 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.595 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 32.5 m-20 -142.03 145.1 34.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 3.7 t80 87.63 87.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 99.5 mttt 68.13 -8.82 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.709 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.62 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 96.8 m -64.35 -35.31 80.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.365 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.556 ' HB3' ' C ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 23.5 tptm -105.56 -4.0 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.52 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 28' ' ' TYR . . . -59.62 136.8 50.21 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 78.3 ttt-85 -133.85 125.86 29.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.67 -71.04 0.22 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 55.3 Cg_endo -73.02 160.57 45.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.89 2.393 . . . . 0.0 112.17 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' HA2' ' OH ' ' A' ' 28' ' ' TYR . . . -57.22 140.59 44.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.554 ' C ' ' CE2' ' A' ' 28' ' ' TYR . . . 149.58 -171.14 29.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.63 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 31.0 p -82.8 135.27 35.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.525 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.63 ' CD2' ' O ' ' A' ' 27' ' ' CYS . 4.2 p90 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.664 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.676 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.0 m -60.03 -46.08 90.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.696 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.03 HD12 ' CB ' ' A' ' 7' ' ' SER . 96.6 mt -100.89 -41.19 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.169 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.676 ' N ' ' SG ' ' A' ' 1' ' ' CYS . . . 75.12 23.0 75.47 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HB3' ' HD3' ' A' ' 24' ' ' PRO . 76.4 mm-40 -116.27 -4.56 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.817 0.341 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 1.03 ' CB ' HD12 ' A' ' 3' ' ' ILE . 1.3 m -142.33 166.45 21.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 29.3 Cg_endo -64.77 -21.85 64.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.95 2.433 . . . . 0.0 111.77 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.672 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 149.69 -158.7 27.77 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.672 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 25.04 71.64 0.36 Allowed Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.801 ' C ' ' HG3' ' A' ' 13' ' ' DBB . 11.3 Cg_endo -56.34 -88.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.761 2.307 . . . . 0.0 111.786 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.801 ' HG3' ' C ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.883 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 48.4 t30 -98.66 -3.29 36.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.954 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 78.6 m-20 -155.19 -84.77 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 111.168 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.644 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 17.6 t80 -69.29 135.5 50.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.921 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 28' ' ' TYR . 98.1 mttt 68.75 18.88 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -146.15 150.23 35.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.425 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.64 ' O ' ' HG2' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 14' ' ' ASN . 64.4 mttp -92.14 -5.89 51.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 15' ' ' ASP . . . -66.34 81.28 0.11 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 23' ' ' GLY . 79.6 mtp85 -65.3 -37.63 87.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -53.06 -134.61 0.0 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -52.87 -39.18 78.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.719 2.279 . . . . 0.0 112.231 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.69 -120.73 1.09 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' LYS . . . 71.06 63.92 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' C ' ' A' ' 28' ' ' TYR . 6.3 t -83.29 143.06 30.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 110.593 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.56 ' C ' ' O ' ' A' ' 27' ' ' CYS . 39.2 p90 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.757 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.539 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 1.6 t -78.38 -74.07 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.612 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.746 HG21 ' HB3' ' A' ' 11' ' ' ALA . 11.3 tp -104.72 25.03 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.352 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.652 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -83.16 -130.94 1.68 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.88 4.56 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.607 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -166.88 -67.0 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.722 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.66 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 54.1 Cg_endo -70.43 151.02 65.0 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.767 2.311 . . . . 0.0 112.199 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -85.72 -125.02 1.55 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.666 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 24.36 64.58 0.41 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 14' ' ' ASN . 38.3 Cg_exo -54.24 136.81 69.6 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 122.664 2.243 . . . . 0.0 110.972 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.637 ' C ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.79 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 22.1 t-20 -103.49 -36.98 7.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.625 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.543 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 87.0 m-20 -143.16 155.66 44.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.78 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER 81.33 79.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.483 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 63.8 mttp 68.35 -5.18 0.95 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.754 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.637 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 93.2 m -64.55 -44.41 90.86 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.79 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 14' ' ' ASN . 7.6 tttm -152.54 72.1 0.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 27' ' ' CYS . . . -163.28 138.45 5.33 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -81.7 -20.54 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.835 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 28' ' ' TYR . . . -42.88 144.15 1.26 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.25 -25.04 64.89 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.856 2.37 . . . . 0.0 112.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.639 ' C ' ' CE1' ' A' ' 28' ' ' TYR . . . -96.82 146.36 18.25 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 28' ' ' TYR . . . 35.24 -160.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' O ' ' O ' ' A' ' 21' ' ' GLY . 97.6 m -64.91 -38.64 91.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.424 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.639 ' CE1' ' C ' ' A' ' 25' ' ' GLY . 14.5 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.595 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -87.74 -45.28 10.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.011 HD13 ' OD2' ' A' ' 15' ' ' ASP . 3.0 tt -119.78 9.31 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.662 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.633 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -131.13 -124.58 2.6 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.0 tp10 -107.72 -10.05 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.225 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -74.44 154.06 87.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.577 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.31 -20.79 55.17 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.814 2.342 . . . . 0.0 112.062 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . 165.36 -162.3 35.64 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -112.69 76.97 2.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 14' ' ' ASN . 17.1 Cg_endo -59.05 143.27 99.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.586 2.191 . . . . 0.0 111.578 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.673 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.614 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 66.3 t30 -118.93 4.81 11.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 1.011 ' OD2' HD13 ' A' ' 3' ' ' ILE . 64.5 t0 -142.52 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.669 ' HB2' HD11 ' A' ' 3' ' ' ILE . 23.4 t80 -80.05 131.29 35.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.573 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 15.4 tttp 78.84 1.49 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.673 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 1.3 m -132.98 120.94 22.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.326 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.693 ' O ' ' HG2' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -64.35 -43.75 93.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.813 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 14' ' ' ASN . . . -68.04 -42.8 83.97 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HA ' ' CG ' ' A' ' 19' ' ' DBB . 76.0 ttt180 55.52 79.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.693 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.62 -163.4 11.83 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.91 -21.54 57.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.895 2.397 . . . . 0.0 112.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.9 -156.19 7.45 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . 62.94 -130.47 42.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.574 ' O ' ' C ' ' A' ' 28' ' ' TYR . 14.8 t 71.52 138.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.598 ' CE1' ' HA ' ' A' ' 19' ' ' DBB . 93.6 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.752 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.503 ' C ' ' H1 ' ' A' ' 4' ' ' DBB . 72.1 m -88.81 -74.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.393 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.66 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.2 mp -70.91 -3.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.66 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.609 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -165.45 -16.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -93.61 -66.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.307 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 155.8 -64.15 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.76 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 35.3 Cg_endo -67.26 -17.38 49.91 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.967 2.444 . . . . 0.0 112.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.653 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 72.22 -128.63 13.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.653 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' C ' ' O ' ' A' ' 10' ' ' DAL . . . 26.99 66.15 0.54 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.406 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 14' ' ' ASN . 15.3 Cg_endo -58.4 134.71 63.1 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.515 ' C ' ' O ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 12' ' ' PRO . 47.6 t30 -115.48 0.71 13.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.673 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.582 ' OD1' ' CA ' ' A' ' 21' ' ' GLY . 31.2 t70 -155.08 -86.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.645 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 56.8 t80 -70.96 131.48 43.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 23.4 mtpt 61.43 33.14 18.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.046 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -136.7 -18.82 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.582 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.621 ' O ' ' HG2' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.8 -5.7 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.675 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -96.82 120.79 6.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' GLY . 90.1 mtm180 -96.87 0.63 49.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -55.69 -152.74 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.45 -39.32 82.43 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.839 2.359 . . . . 0.0 112.153 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.79 -167.84 38.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.597 ' HA3' ' CD1' ' A' ' 16' ' ' TYR . . . 99.81 103.67 2.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 28' ' ' TYR . 7.6 t -135.67 133.78 38.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 110.665 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.58 ' N ' ' N ' ' A' ' 18' ' ' CYS . 95.1 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.627 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -79.8 -46.03 17.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.333 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.672 ' O ' ' C ' ' A' ' 4' ' ' DBB . 4.2 tp -121.42 5.79 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.488 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.672 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.619 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -160.81 -148.88 5.42 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -100.83 -5.93 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.06 0.457 . . . . 0.0 110.1 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -72.11 176.4 2.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.377 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 9' ' ' GLY . 56.1 Cg_endo -71.77 159.23 51.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.66 2.24 . . . . 0.0 111.88 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.689 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -51.71 -156.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.689 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 45.69 61.99 11.6 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ASN . 32.9 Cg_exo -51.91 135.06 50.26 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.54 2.16 . . . . 0.0 111.036 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.524 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' PRO . 35.6 t30 -119.19 -1.64 10.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.698 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' A' ' 16' ' ' TYR . 54.0 p-10 -150.2 -136.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.561 ' CD1' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER 26.68 -93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.592 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ASP . 56.5 mtmt -130.09 76.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.782 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 3.1 m -135.14 -1.74 2.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.492 ' HB3' ' H ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 58.1 tptt -147.67 147.03 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.578 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.635 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 114.99 171.45 16.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -131.62 146.36 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.48 151.73 8.3 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.99 144.81 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.977 2.451 . . . . 0.0 112.1 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.79 152.9 22.77 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.77 -172.59 14.47 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.635 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -57.39 -178.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CD2' ' O ' ' A' ' 27' ' ' CYS . 55.6 p90 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 8' ' ' PRO . 10.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.4 -37.69 10.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.173 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.86 HD11 ' HB2' ' A' ' 11' ' ' ALA . 40.0 mt -103.86 -1.46 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.963 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.675 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -129.62 -97.01 0.81 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.26 -5.49 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.648 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -173.13 80.69 0.41 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.341 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 12.1 Cg_endo -56.53 -41.46 75.8 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 112.212 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . 34.75 24.62 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.618 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.86 ' HB2' HD11 ' A' ' 3' ' ' ILE . . . 38.92 62.91 4.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.767 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' O ' ' HB3' ' A' ' 13' ' ' DBB . 31.5 Cg_endo -66.74 -19.5 53.29 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.888 2.392 . . . . 0.0 111.747 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.593 ' HG3' ' H ' ' A' ' 15' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' OD1' ' CB ' ' A' ' 20' ' ' LYS . 65.0 t30 -120.47 17.83 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.971 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.69 ' OD2' HG23 ' A' ' 3' ' ' ILE . 63.8 t0 -141.52 -107.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.137 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 18' ' ' CYS . 39.7 p90 -53.94 144.67 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.772 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 99.0 mttt 32.61 30.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.594 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' TYR . 1.1 m -141.44 -27.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.613 ' HG2' ' HA ' ' A' ' 15' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 57.8 mtpt 52.07 27.43 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.191 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.92 173.09 42.83 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -112.28 131.65 55.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.7 -118.6 0.88 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 25' ' ' GLY . 59.9 Cg_endo -73.2 157.4 50.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.823 2.349 . . . . 0.0 112.183 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 24' ' ' PRO . . . -51.52 -162.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 17' ' ' LYS . . . 82.27 20.34 62.74 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.568 ' HA ' ' CA ' ' A' ' 19' ' ' DBB . 0.0 OUTLIER -99.72 139.22 35.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.432 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.512 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.646 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.746 ' O ' ' HG2' ' A' ' 4' ' ' DBB . 2.7 t -79.01 134.48 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.654 HG23 ' O ' ' A' ' 3' ' ' ILE . 1.8 tp 54.63 9.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 123.309 0.381 . . . . 0.0 110.246 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.746 ' HG2' ' O ' ' A' ' 2' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -108.88 -158.73 19.03 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -103.86 -5.01 22.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 110.52 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.13 172.79 1.72 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -53.39 -38.18 82.38 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.866 2.377 . . . . 0.0 112.182 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.547 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 153.02 -164.88 31.01 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.647 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.794 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -117.78 69.24 6.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.583 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.647 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 35.2 Cg_exo -52.6 137.84 58.38 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.718 2.279 . . . . 0.0 111.782 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.658 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.794 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 61.4 t-20 -116.78 -28.15 6.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.532 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.615 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 98.7 m-20 -118.69 155.4 31.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.609 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.615 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 92.56 11.58 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.772 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 56.8 mttp 88.21 39.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.42 0.45 . . . . 0.0 110.905 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 10.9 t -82.95 -16.68 46.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 14' ' ' ASN . 57.8 mtpt -138.52 159.18 42.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.764 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.533 ' C ' ' HB3' ' A' ' 28' ' ' TYR . . . 139.89 149.35 5.33 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -94.67 -5.44 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.781 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 28' ' ' TYR . . . -80.87 159.85 42.35 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.69 143.72 47.13 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.906 2.404 . . . . 0.0 111.979 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.06 -174.97 19.83 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.638 ' O ' ' SG ' ' A' ' 27' ' ' CYS . . . 65.59 28.45 73.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.638 ' SG ' ' O ' ' A' ' 26' ' ' GLY . 2.1 p 51.94 11.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.549 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 26' ' ' GLY . 11.6 m-30 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.702 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.727 ' CB ' ' H ' ' A' ' 10' ' ' DAL . 3.1 m -63.44 -45.07 92.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.224 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.744 HD12 ' OG ' ' A' ' 7' ' ' SER . 85.5 mt -117.86 -29.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.381 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.87 25.82 55.04 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -108.8 -4.15 17.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.369 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.744 ' OG ' HD12 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -143.75 -175.48 0.48 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.763 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.4 Cg_exo -52.4 -38.2 73.35 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.991 2.46 . . . . 0.0 112.064 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.647 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 118.48 168.49 14.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.727 ' H ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.711 ' HB3' HD11 ' A' ' 3' ' ' ILE . . . -112.07 75.33 1.56 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 110.488 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.23 142.07 97.1 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.849 2.366 . . . . 0.0 111.915 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.708 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.69 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 63.6 t30 -125.66 123.89 39.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.437 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.74 ' HB2' HD13 ' A' ' 3' ' ' ILE . 1.0 OUTLIER 68.88 -76.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.794 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.675 ' O ' ' HG3' ' A' ' 13' ' ' DBB . 25.0 t80 -70.88 126.47 29.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 28' ' ' TYR . 98.0 mttt 58.29 3.67 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.708 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.8 OUTLIER -138.5 117.15 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.517 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.558 ' HG2' ' O ' ' A' ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 18' ' ' CYS . 99.3 mttt -82.48 -11.7 58.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 19' ' ' DBB . . . -106.62 -175.19 23.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.31 145.31 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.62 36.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -53.29 -38.33 81.81 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.863 2.375 . . . . 0.0 112.062 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.94 -170.05 32.2 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 79.02 11.49 85.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -47.85 -67.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 0.0 110.477 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.524 ' C ' ' HA ' ' A' ' 17' ' ' LYS . 6.5 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.625 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.432 ' CB ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -87.65 -83.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.878 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.612 HG22 ' HB3' ' A' ' 15' ' ' ASP . 5.6 pt -70.43 -42.58 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.094 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.547 ' N ' ' CG1' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 3' ' ' ILE . . . -124.11 -145.85 6.81 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.07 6.08 28.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.756 0.312 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.579 ' OG ' ' CD1' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -70.82 177.77 1.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 7' ' ' SER . 47.1 Cg_exo -53.89 -38.18 85.81 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.766 2.311 . . . . 0.0 112.014 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . 133.94 -110.56 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.627 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -111.04 72.31 0.81 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 110.152 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.627 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 24.4 Cg_exo -50.71 142.33 32.39 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.678 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 58.6 t-20 -156.3 19.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.561 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 17' ' ' LYS . 4.5 p-10 -119.74 94.94 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 51.0 p90 32.52 28.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.13 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.629 ' N ' ' O ' ' A' ' 15' ' ' ASP . 83.0 mttt -152.35 24.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.678 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.1 OUTLIER -155.9 54.33 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.736 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.516 ' C ' ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' CYS . 99.0 mttt -136.27 153.19 51.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.85 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.16 157.17 8.32 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -125.99 135.39 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.69 -103.44 1.93 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.59 150.73 51.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.877 2.385 . . . . 0.0 112.132 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.71 47.25 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 167.19 99.38 0.13 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 28' ' ' TYR . 5.2 t -119.13 119.08 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 110.574 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' H ' ' N ' ' A' ' 18' ' ' CYS . 31.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.607 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -92.62 -57.88 2.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.139 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.681 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.2 mp -79.9 -4.96 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.052 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.681 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.538 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -126.9 -120.58 2.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.86 14.53 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 69.5 p -103.35 171.65 4.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.555 ' O ' ' O ' ' A' ' 9' ' ' GLY . 23.9 Cg_exo -62.09 146.66 96.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 123.017 2.478 . . . . 0.0 112.014 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -43.08 177.12 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.606 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 177.37 72.49 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.223 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 14' ' ' ASN . 9.9 Cg_endo -53.09 137.33 62.61 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.874 2.383 . . . . 0.0 111.721 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.678 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.792 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 25.8 t-20 -118.67 -1.8 11.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.532 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.583 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 62.8 m-20 -161.97 175.5 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 70.0 t80 72.45 -64.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 60.6 mttm -153.92 66.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 0.0 OUTLIER -151.35 47.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.655 ' H1 ' ' H ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 74.8 mmtt -126.04 145.37 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.86 112.01 1.12 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 8' ' ' PRO . 83.9 mtt85 -66.54 -38.96 88.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.756 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 24' ' ' PRO . . . -88.75 -135.0 5.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.577 ' O ' ' C ' ' A' ' 25' ' ' GLY . 36.8 Cg_endo -66.91 -19.49 52.27 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.87 2.38 . . . . 0.0 112.25 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 24' ' ' PRO . . . -19.48 130.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -78.6 175.89 54.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.706 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 5.9 t -109.16 177.65 4.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.662 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.706 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 18.1 p90 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.778 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.584 ' SG ' ' HG3' ' A' ' 8' ' ' PRO . 9.0 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.971 ' SG ' HD13 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -95.6 -39.33 9.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.033 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.971 HD13 ' SG ' ' A' ' 2' ' ' CYS . 1.1 mp -101.21 -3.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.2 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.674 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.615 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -122.65 -110.3 2.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.4 tp10 -125.51 -13.25 6.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.9 0.381 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.556 ' O ' ' OG ' ' A' ' 7' ' ' SER . 6.1 p -145.57 73.68 13.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 31.9 Cg_exo -54.92 -149.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.904 2.402 . . . . 0.0 112.202 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.22 67.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 15' ' ' ASP . . . 60.47 54.65 3.71 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.718 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.2 Cg_endo -70.33 44.93 0.49 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.781 2.32 . . . . 0.0 112.074 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 2.2 t-20 -125.07 -13.1 6.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.022 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.588 ' OD1' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -156.81 66.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.599 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.563 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 4.1 t80 174.08 84.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.869 0.366 . . . . 0.0 110.491 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.542 ' H ' ' CZ ' ' A' ' 22' ' ' ARG . 97.4 mttt 53.46 7.89 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.333 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' TYR . 38.3 m -65.78 -38.19 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.391 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.577 ' HB3' ' N ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.629 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 60.5 tptt -107.24 159.7 16.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.484 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' OD1' ' A' ' 15' ' ' ASP . . . -57.06 161.94 7.74 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.603 ' HB2' ' CE2' ' A' ' 28' ' ' TYR . 38.9 mtm-85 -153.81 -164.12 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.719 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.88 -78.79 1.41 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -53.52 -38.83 83.79 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.86 2.373 . . . . 0.0 112.317 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' CA ' ' OH ' ' A' ' 28' ' ' TYR . . . 147.82 152.39 5.67 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' N ' ' CZ ' ' A' ' 28' ' ' TYR . . . -173.35 -178.36 43.27 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HB2' ' HG1' ' A' ' 19' ' ' DBB . 15.4 p -62.16 -52.06 65.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' N ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 m-30 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.673 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -93.02 -45.58 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.593 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.882 HD11 ' HB2' ' A' ' 16' ' ' TYR . 3.7 tp -109.19 5.08 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.654 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.613 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -118.77 -128.72 3.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.5 tp10 -109.23 -10.66 14.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.4 m -84.4 165.84 36.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.61 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 7' ' ' SER . 46.4 Cg_exo -53.69 -38.36 84.54 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.763 2.308 . . . . 0.0 112.023 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.659 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 174.59 -121.96 0.86 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.659 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 25.25 62.16 0.45 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.861 ' C ' ' HG3' ' A' ' 13' ' ' DBB . 24.6 Cg_exo -53.11 -73.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.763 2.309 . . . . 0.0 112.158 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.861 ' HG3' ' C ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.912 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 12.5 t-20 -108.82 8.99 26.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.7 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.576 ' OD2' ' CG2' ' A' ' 3' ' ' ILE . 61.6 t0 -156.72 -87.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.378 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.882 ' HB2' HD11 ' A' ' 3' ' ' ILE . 22.8 t80 -68.57 130.73 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 9.0 ttmt 68.7 10.2 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.256 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -141.26 -20.7 0.77 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.623 ' O ' ' CG ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' DBB . 14.7 tttp 36.13 26.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.348 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' DBB . . . -126.92 156.03 20.02 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 62.5 ttp180 -61.61 -43.12 99.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.22 126.14 9.23 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.99 156.06 47.74 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.944 2.43 . . . . 0.0 112.39 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.33 145.08 18.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 63.72 27.58 71.3 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.57 ' HA ' ' N ' ' A' ' 19' ' ' DBB . 84.1 m -102.01 147.24 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.219 0.533 . . . . 0.0 111.18 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.472 ' H ' ' C ' ' A' ' 18' ' ' CYS . 21.1 m-30 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.524 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.472 ' CB ' ' H ' ' A' ' 10' ' ' DAL . 0.1 OUTLIER -67.77 -83.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.615 ' O ' ' C ' ' A' ' 4' ' ' DBB . 10.7 tp -98.87 19.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.273 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.615 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.585 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -142.88 -164.94 10.4 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.52 -5.32 22.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -58.38 -175.51 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 45.7 Cg_exo -53.27 -38.08 81.44 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.746 2.298 . . . . 0.0 111.896 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.639 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 103.5 164.83 25.38 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.639 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -113.95 71.89 2.06 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.862 0.363 . . . . 0.0 110.176 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 13' ' ' DBB . 18.5 Cg_endo -60.38 147.33 94.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.608 2.205 . . . . 0.0 111.009 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.58 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.851 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 2.0 t-20 -136.71 43.19 2.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.488 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.623 ' O ' ' C ' ' A' ' 16' ' ' TYR . 67.6 t0 176.92 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.623 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 9.25 -82.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.266 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ASP . 68.5 mttm -138.63 29.61 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.455 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.665 ' C ' ' SG ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER -102.28 -68.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.583 ' O ' ' HG3' ' A' ' 20' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.62 ' H ' ' HB3' ' A' ' 27' ' ' CYS . 16.6 mttm 163.33 -94.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.55 125.35 2.79 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.522 ' CG ' ' HA3' ' A' ' 5' ' ' GLY . 62.2 ttp180 -63.41 -43.06 98.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.741 0.305 . . . . 0.0 110.692 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.68 -120.68 1.65 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.32 -38.7 82.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.717 2.278 . . . . 0.0 112.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.31 126.28 1.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' TYR . . . -133.63 -68.89 0.08 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.719 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 43.3 t -66.43 -111.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.719 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p90 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.636 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.638 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -79.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.419 . . . . 0.0 109.934 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.541 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 1.2 mp -65.28 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.901 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.527 ' HG1' ' HB2' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.71 -108.23 1.1 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.3 tp10 -106.37 -11.32 16.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 110.604 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.521 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 1.3 m -60.92 125.8 84.23 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -53.51 -39.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.859 2.373 . . . . 0.0 112.141 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -179.75 -166.31 35.16 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' DAL . . . . . 0.663 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . 43.51 59.97 11.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.042 0.448 . . . . 0.0 110.533 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' C ' ' N ' ' A' ' 14' ' ' ASN . 11.8 Cg_endo -58.21 137.6 81.5 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.792 2.328 . . . . 0.0 111.817 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.725 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.555 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 66.2 t30 -137.14 15.83 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.451 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.666 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 30.2 t0 175.07 173.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.78 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.666 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 16.9 p90 48.71 11.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 51.3 mttt 150.33 45.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.437 0.46 . . . . 0.0 110.532 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.725 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 1.1 m -171.53 88.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' DBB . . . . . 0.548 ' C ' ' HG3' ' A' ' 20' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.9 mttt -158.33 152.75 24.42 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.669 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.574 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -158.34 -142.52 3.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -61.12 -42.44 98.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.653 0.263 . . . . 0.0 110.54 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.94 -71.16 0.1 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.54 -20.25 47.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.872 2.381 . . . . 0.0 112.105 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 21' ' ' GLY . . . -168.11 -141.14 3.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 21' ' ' GLY . . . 86.66 13.65 66.95 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.551 ' SG ' ' HD1' ' A' ' 28' ' ' TYR . 1.7 t -87.24 130.8 34.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 110.643 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.551 ' HD1' ' SG ' ' A' ' 27' ' ' CYS . 12.5 m-85 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.492 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -67.07 -46.65 73.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 110.002 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.592 ' CD1' ' CB ' ' A' ' 7' ' ' SER . 50.3 pt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.198 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.1 10.75 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.598 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -86.88 -175.04 0.54 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.1 Cg_exo -52.63 -38.38 75.99 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.745 2.297 . . . . 0.0 112.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.612 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.073 0.463 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 C--N 1.304 -1.785 0 C-N-CA 123.008 2.472 . . . . 0.0 111.417 179.708 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.522 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.2 t-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.865 0.364 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 11' ' ' ALA . 53.7 p-10 -135.78 -147.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.551 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . 15.7 p90 -76.28 34.11 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.211 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 27' ' ' CYS . 67.6 mttm -153.44 18.18 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.947 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 27' ' ' CYS . 3.5 m . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.7 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 118.8 -158.3 14.88 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -128.98 147.84 50.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.08 143.53 4.07 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.54 -38.34 83.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.811 2.341 . . . . 0.0 112.001 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.55 -163.11 10.1 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 16' ' ' TYR . . . 69.27 105.31 0.03 OUTLIER Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 18' ' ' CYS . 8.6 t . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.857 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HG ' ' N ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -59.42 -41.29 89.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.601 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 10.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.267 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.407 ' N ' ' HG ' ' A' ' 1' ' ' CYS . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 81.3 tt0 -88.2 -9.97 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 0.0 110.377 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER 57.39 52.17 5.5 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 7' ' ' SER . 34.1 Cg_endo -66.73 -20.29 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.818 2.345 . . . . 0.0 112.128 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.025 0.44 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.1 Cg_endo . . . . . 0 C--N 1.304 -1.802 0 C-N-CA 123.009 2.473 . . . . 0.0 111.692 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' O ' ' A' ' 20' ' ' LYS . 9.6 t30 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.69 0.281 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.582 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 27.5 t0 -162.03 176.1 11.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.857 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HD2' ' HB2' ' A' ' 17' ' ' LYS . 60.3 t80 54.25 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.866 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.58 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 8.7 ttmt -111.87 62.83 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.742 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' O ' ' N ' ' A' ' 20' ' ' LYS . 1.3 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' CYS . 75.7 mmtt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.763 0.316 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.43 95.17 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.553 ' O ' ' O ' ' A' ' 23' ' ' GLY . 72.8 ttp85 -63.57 -42.91 98.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -54.08 -129.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.16 -38.17 80.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.794 2.329 . . . . 0.0 112.22 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 -142.51 17.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.23 161.58 36.68 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 18' ' ' CYS . 5.5 t . . . . . 0 C--N 1.329 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.588 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.524 ' HB3' HD12 ' A' ' 3' ' ' ILE . 53.7 t -47.39 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.119 HD11 ' O ' ' A' ' 9' ' ' GLY . 3.6 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 97.9 mt-10 -135.32 16.6 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.652 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.57 176.51 2.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.645 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 46.1 Cg_exo -53.11 -39.49 79.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.828 2.352 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 1.119 ' O ' HD11 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 C-N-CA 123.023 2.482 . . . . 0.0 111.847 179.583 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.561 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.4 t-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.706 0.289 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.642 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 52.4 p-10 -128.92 -140.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.956 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 52.3 p90 -37.13 139.16 0.24 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.451 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 98.6 mttt 49.15 14.28 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.467 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 56.2 mtmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.13 -167.85 11.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 7' ' ' SER . 24.8 tpt180 -115.2 132.05 56.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 6' ' ' GLU . . . 125.26 153.77 8.59 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.55 155.79 54.5 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.914 2.409 . . . . 0.0 112.102 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . 118.47 170.2 14.79 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 25' ' ' GLY . . . -26.88 89.75 0.01 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 1.7 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.825 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 t -79.86 131.35 35.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.589 HG13 ' CE2' ' A' ' 16' ' ' TYR . 1.1 mp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.885 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.714 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 7' ' ' SER . 19.6 pt-20 -105.47 -6.61 19.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 9.9 p -38.2 154.36 0.13 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 -20.8 55.15 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.822 2.348 . . . . 0.0 111.957 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.953 0.406 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 C--N 1.3 -2.001 0 C-N-CA 122.395 2.063 . . . . 0.0 111.508 179.637 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.742 ' N ' ' HG ' ' A' ' 18' ' ' CYS . 23.1 t-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 7' ' ' SER . 11.4 t70 -138.88 -46.23 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 52.0 p90 -135.93 137.53 41.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 26' ' ' GLY . 57.8 mtpt 61.61 29.17 18.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.742 ' HG ' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.442 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 68.9 mttm . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.776 0.322 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 15' ' ' ASP . . . -98.29 151.89 19.7 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 89.0 mtm180 -64.56 -39.25 93.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.559 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.04 106.09 0.42 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 36.7 Cg_endo -67.99 -17.91 46.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.845 2.364 . . . . 0.0 112.188 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.6 95.98 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 17' ' ' LYS . . . -120.32 109.83 1.66 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.82 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.642 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -81.96 -47.5 12.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 110.369 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.683 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.183 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.47 ' N ' HG23 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.564 ' OE2' ' O ' ' A' ' 22' ' ' ARG . 17.2 pt-20 -108.95 -8.2 15.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 8' ' ' PRO . 24.4 m -120.15 72.29 18.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.683 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 7' ' ' SER . 48.8 Cg_exo -50.72 -145.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.866 2.377 . . . . 0.0 112.439 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.599 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 11' ' ' ALA . 22.4 Cg_exo . . . . . 0 C--N 1.305 -1.749 0 C-N-CA 123.101 2.534 . . . . 0.0 111.733 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 20' ' ' LYS . 54.4 t30 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 3.1 m-20 -157.43 169.57 24.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.566 ' HB2' ' CG1' ' A' ' 3' ' ' ILE . 65.2 t80 77.45 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.704 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.569 ' O ' ' O ' ' A' ' 27' ' ' CYS . 72.5 tttt -118.95 33.28 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.53 ' C ' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 14' ' ' ASN . 64.5 mttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.537 ' HA2' ' OD2' ' A' ' 15' ' ' ASP . . . 125.97 163.17 11.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.564 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mtt-85 -128.13 149.29 50.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.688 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.85 -106.86 1.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -54.34 -34.71 81.54 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.11 10.83 70.87 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -62.83 148.93 49.67 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.6 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.69 0.281 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.994 HD12 ' CB ' ' A' ' 7' ' ' SER . 67.0 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.799 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 83.6 tt0 -113.65 -7.28 13.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.994 ' CB ' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -56.13 145.25 56.53 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.26 -21.17 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.885 2.39 . . . . 0.0 112.096 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.616 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.1 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 C-N-CA 122.789 2.326 . . . . 0.0 111.723 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.0 t30 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.595 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 32.5 m-20 -142.03 145.1 34.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 3.7 t80 87.63 87.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 99.5 mttt 68.13 -8.82 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.709 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.599 ' HG ' ' N ' ' A' ' 14' ' ' ASN . 96.8 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.365 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 23.5 tptm . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.847 0.356 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.522 ' HA2' ' OD1' ' A' ' 15' ' ' ASP . . . -59.62 136.8 50.21 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 78.3 ttt-85 -133.85 125.86 29.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.67 -71.04 0.22 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 55.3 Cg_endo -73.02 160.57 45.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.89 2.393 . . . . 0.0 112.17 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.22 140.59 44.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.58 -171.14 29.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.0 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.525 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.734 ' HG ' ' N ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.0 m -60.03 -46.08 90.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.696 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.03 HD12 ' CB ' ' A' ' 7' ' ' SER . 96.6 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.169 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.734 ' N ' ' HG ' ' A' ' 1' ' ' CYS . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HB3' ' HD3' ' A' ' 24' ' ' PRO . 76.4 mm-40 -116.27 -4.56 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.817 0.341 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 1.03 ' CB ' HD12 ' A' ' 3' ' ' ILE . 1.3 m -142.33 166.45 21.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 29.3 Cg_endo -64.77 -21.85 64.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.95 2.433 . . . . 0.0 111.77 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 11.3 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 C-N-CA 122.761 2.307 . . . . 0.0 111.786 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.883 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 48.4 t30 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.617 0.246 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 78.6 m-20 -155.19 -84.77 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 111.168 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.644 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 17.6 t80 -69.29 135.5 50.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.921 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.508 ' HE3' ' CE2' ' A' ' 16' ' ' TYR . 98.1 mttt 68.75 18.88 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.425 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 14' ' ' ASN . 64.4 mttp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 15' ' ' ASP . . . -66.34 81.28 0.11 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 23' ' ' GLY . 79.6 mtp85 -65.3 -37.63 87.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -53.06 -134.61 0.0 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -52.87 -39.18 78.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.719 2.279 . . . . 0.0 112.231 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.69 -120.73 1.09 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' LYS . . . 71.06 63.92 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' CYS . 6.3 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.539 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 1.6 t -78.38 -74.07 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.612 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.746 HG21 ' HB3' ' A' ' 11' ' ' ALA . 11.3 tp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.352 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.541 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.88 4.56 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.607 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -166.88 -67.0 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.722 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.66 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 54.1 Cg_endo -70.43 151.02 65.0 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.767 2.311 . . . . 0.0 112.199 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.539 ' C ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 14' ' ' ASN . 38.3 Cg_exo . . . . . 0 C--N 1.3 -2.0 0 C-N-CA 122.664 2.243 . . . . 0.0 110.972 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.79 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 7.2 t30 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.884 0.373 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.543 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 87.0 m-20 -143.16 155.66 44.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.78 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER 81.33 79.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.483 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 63.8 mttp 68.35 -5.18 0.95 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.754 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' H ' ' C ' ' A' ' 16' ' ' TYR . 93.2 m . . . . . 0 C--N 1.332 -0.174 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.79 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 14' ' ' ASN . 7.6 tttm . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.669 0.271 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 27' ' ' CYS . . . -163.28 138.45 5.33 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -81.7 -20.54 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.835 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -42.88 144.15 1.26 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.25 -25.04 64.89 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.856 2.37 . . . . 0.0 112.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 26' ' ' GLY . . . -96.82 146.36 18.25 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 25' ' ' GLY . . . 35.24 -160.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.593 ' O ' ' O ' ' A' ' 21' ' ' GLY . 97.6 m . . . . . 0 C--N 1.326 -0.416 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.424 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -87.74 -45.28 10.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.011 HD13 ' OD2' ' A' ' 15' ' ' ASP . 3.0 tt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.295 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.0 tp10 -107.72 -10.05 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.225 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -74.44 154.06 87.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.577 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.31 -20.79 55.17 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.814 2.342 . . . . 0.0 112.062 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.586 2.191 . . . . 0.0 111.578 179.841 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.614 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 66.3 t30 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.737 0.303 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 1.011 ' OD2' HD13 ' A' ' 3' ' ' ILE . 64.5 t0 -142.52 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.669 ' HB2' HD11 ' A' ' 3' ' ' ILE . 23.4 t80 -80.05 131.29 35.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 15.4 tttp 78.84 1.49 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' C ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.326 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 14' ' ' ASN . . . -68.04 -42.8 83.97 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 55.52 79.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.62 -163.4 11.83 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.91 -21.54 57.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.895 2.397 . . . . 0.0 112.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.9 -156.19 7.45 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . 62.94 -130.47 42.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HA ' ' C ' ' A' ' 18' ' ' CYS . 14.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.1 m -88.81 -74.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.56 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.328 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -93.61 -66.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.307 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 155.8 -64.15 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.76 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 35.3 Cg_endo -67.26 -17.38 49.91 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.967 2.444 . . . . 0.0 112.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.424 ' N ' ' OE1' ' A' ' 6' ' ' GLU . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.779 0.323 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 14' ' ' ASN . 15.3 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' N ' ' HG ' ' A' ' 18' ' ' CYS . 47.6 t30 . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.582 ' OD1' ' CA ' ' A' ' 21' ' ' GLY . 31.2 t70 -155.08 -86.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.645 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 56.8 t80 -70.96 131.48 43.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 26' ' ' GLY . 23.4 mtpt 61.43 33.14 18.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.046 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.582 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.825 0.345 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -96.82 120.79 6.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' GLY . 90.1 mtm180 -96.87 0.63 49.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -55.69 -152.74 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.45 -39.32 82.43 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.839 2.359 . . . . 0.0 112.153 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.79 -167.84 38.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.597 ' HA3' ' CD1' ' A' ' 16' ' ' TYR . . . 99.81 103.67 2.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.466 ' C ' ' HA ' ' A' ' 17' ' ' LYS . 7.6 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 110.665 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -79.8 -46.03 17.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.333 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.561 HD12 ' CD1' ' A' ' 16' ' ' TYR . 4.2 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.488 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -100.83 -5.93 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.06 0.457 . . . . 0.0 110.1 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -72.11 176.4 2.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.377 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 9' ' ' GLY . 56.1 Cg_endo -71.77 159.23 51.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.66 2.24 . . . . 0.0 111.88 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ASN . 32.9 Cg_exo . . . . . 0 C--N 1.301 -1.93 0 C-N-CA 122.54 2.16 . . . . 0.0 111.036 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' PRO . 35.6 t30 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.799 0.333 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' A' ' 16' ' ' TYR . 54.0 p-10 -150.2 -136.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.561 ' CD1' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER 26.68 -93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.592 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ASP . 56.5 mtmt -130.09 76.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.782 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.909 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.75 0.309 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.99 171.45 16.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -131.62 146.36 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.48 151.73 8.3 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.99 144.81 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.977 2.451 . . . . 0.0 112.1 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.79 152.9 22.77 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.77 -172.59 14.47 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 8' ' ' PRO . 10.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.4 -37.69 10.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.173 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.86 HD11 ' HB2' ' A' ' 11' ' ' ALA . 40.0 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.963 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.26 -5.49 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.648 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -173.13 80.69 0.41 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.341 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 12.1 Cg_endo -56.53 -41.46 75.8 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 112.212 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.86 ' HB2' HD11 ' A' ' 3' ' ' ILE . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 C-N-CA 122.888 2.392 . . . . 0.0 111.747 179.839 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' OD1' ' CB ' ' A' ' 20' ' ' LYS . 65.0 t30 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.544 0.211 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.69 ' OD2' HG23 ' A' ' 3' ' ' ILE . 63.8 t0 -141.52 -107.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.137 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 18' ' ' CYS . 39.7 p90 -53.94 144.67 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.772 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.557 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 99.0 mttt 32.61 30.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.594 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' TYR . 1.1 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.663 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 57.8 mtpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.802 0.334 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.92 173.09 42.83 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -112.28 131.65 55.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.7 -118.6 0.88 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 25' ' ' GLY . 59.9 Cg_endo -73.2 157.4 50.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.823 2.349 . . . . 0.0 112.183 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 24' ' ' PRO . . . -51.52 -162.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 17' ' ' LYS . . . 82.27 20.34 62.74 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.432 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.646 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.605 ' O ' HG22 ' A' ' 3' ' ' ILE . 2.7 t -79.01 134.48 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.654 HG23 ' O ' ' A' ' 3' ' ' ILE . 1.8 tp . . . . . 0 C--N 1.331 -0.207 0 O-C-N 123.309 0.381 . . . . 0.0 110.246 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.582 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -103.86 -5.01 22.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 110.52 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.13 172.79 1.72 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -53.39 -38.18 82.38 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.866 2.377 . . . . 0.0 112.182 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.794 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.996 0.426 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo . . . . . 0 C--N 1.301 -1.949 0 C-N-CA 122.718 2.279 . . . . 0.0 111.782 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.794 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 61.4 t-20 . . . . . 0 C--O 1.228 -0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.615 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 98.7 m-20 -118.69 155.4 31.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.609 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.615 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 92.56 11.58 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.772 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 56.8 mttp 88.21 39.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.42 0.45 . . . . 0.0 110.905 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 179.77 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 14' ' ' ASN . 57.8 mtpt . . . . . 0 N--CA 1.46 0.048 0 CA-C-O 120.901 0.381 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.89 149.35 5.33 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -94.67 -5.44 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.781 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.87 159.85 42.35 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.69 143.72 47.13 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.906 2.404 . . . . 0.0 111.979 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.06 -174.97 19.83 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.638 ' O ' ' SG ' ' A' ' 27' ' ' CYS . . . 65.59 28.45 73.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.638 ' SG ' ' O ' ' A' ' 26' ' ' GLY . 2.1 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.549 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.1 m -63.44 -45.07 92.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.224 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.744 HD12 ' OG ' ' A' ' 7' ' ' SER . 85.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.381 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -108.8 -4.15 17.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.369 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.744 ' OG ' HD12 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -143.75 -175.48 0.48 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.763 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.4 Cg_exo -52.4 -38.2 73.35 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.991 2.46 . . . . 0.0 112.064 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.888 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.711 ' HB3' HD11 ' A' ' 3' ' ' ILE . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.095 0.474 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo . . . . . 0 C--N 1.301 -1.929 0 C-N-CA 122.849 2.366 . . . . 0.0 111.915 179.682 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.69 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 63.6 t30 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.74 ' HB2' HD13 ' A' ' 3' ' ' ILE . 1.0 OUTLIER 68.88 -76.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.794 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 25.0 t80 -70.88 126.47 29.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HE3' ' CE2' ' A' ' 16' ' ' TYR . 98.0 mttt 58.29 3.67 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.552 ' HA3' ' CG ' ' A' ' 15' ' ' ASP . . . -106.62 -175.19 23.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.31 145.31 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.62 36.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -53.29 -38.33 81.81 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.863 2.375 . . . . 0.0 112.062 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.94 -170.05 32.2 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 79.02 11.49 85.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 0.0 110.477 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.432 ' CB ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -87.65 -83.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.878 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.612 HG22 ' HB3' ' A' ' 15' ' ' ASP . 5.6 pt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.094 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.07 6.08 28.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.756 0.312 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.579 ' OG ' ' CD1' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -70.82 177.77 1.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 7' ' ' SER . 47.1 Cg_exo -53.89 -38.18 85.81 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.766 2.311 . . . . 0.0 112.014 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.304 -1.793 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.66 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 58.6 t-20 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.702 0.287 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 17' ' ' LYS . 4.5 p-10 -119.74 94.94 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 51.0 p90 32.52 28.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.13 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.629 ' N ' ' O ' ' A' ' 15' ' ' ASP . 83.0 mttt -152.35 24.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.736 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' CYS . 99.0 mttt . . . . . 0 CA--C 1.526 0.054 0 CA-C-O 120.793 0.33 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.16 157.17 8.32 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -125.99 135.39 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.69 -103.44 1.93 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.59 150.73 51.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.877 2.385 . . . . 0.0 112.132 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.71 47.25 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 167.19 99.38 0.13 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 110.574 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -92.62 -57.88 2.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.139 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.55 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.052 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.86 14.53 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 69.5 p -103.35 171.65 4.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.555 ' O ' ' O ' ' A' ' 9' ' ' GLY . 23.9 Cg_exo -62.09 146.66 96.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 123.017 2.478 . . . . 0.0 112.014 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.874 2.383 . . . . 0.0 111.721 179.689 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.792 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 25.8 t-20 . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.641 0.258 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.583 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 62.8 m-20 -161.97 175.5 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 70.0 t80 72.45 -64.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 16' ' ' TYR . 60.6 mttm -153.92 66.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.562 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 74.8 mmtt . . . . . 0 N--CA 1.46 0.068 0 CA-C-O 120.929 0.395 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.86 112.01 1.12 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 8' ' ' PRO . 83.9 mtt85 -66.54 -38.96 88.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.756 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 24' ' ' PRO . . . -88.75 -135.0 5.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.577 ' O ' ' C ' ' A' ' 25' ' ' GLY . 36.8 Cg_endo -66.91 -19.49 52.27 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.87 2.38 . . . . 0.0 112.25 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 24' ' ' PRO . . . -19.48 130.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -78.6 175.89 54.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 17' ' ' LYS . 5.9 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.584 ' SG ' ' HG3' ' A' ' 8' ' ' PRO . 9.0 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.971 ' SG ' HD13 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -95.6 -39.33 9.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.033 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.971 HD13 ' SG ' ' A' ' 2' ' ' CYS . 1.1 mp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.2 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.4 tp10 -125.51 -13.25 6.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.9 0.381 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' PRO . 6.1 p -145.57 73.68 13.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 31.9 Cg_exo -54.92 -149.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.904 2.402 . . . . 0.0 112.202 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 15' ' ' ASP . . . . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 121.011 0.434 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.2 Cg_endo . . . . . 0 C--N 1.304 -1.806 0 C-N-CA 122.781 2.32 . . . . 0.0 112.074 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG ' ' A' ' 7' ' ' SER . 11.9 t30 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.701 0.286 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.588 ' OD1' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -156.81 66.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.599 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.563 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 4.1 t80 174.08 84.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.869 0.366 . . . . 0.0 110.491 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.542 ' H ' ' CZ ' ' A' ' 22' ' ' ARG . 97.4 mttt 53.46 7.89 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.333 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' TYR . 38.3 m . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HG3' ' N ' ' A' ' 21' ' ' GLY . 60.5 tptt . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' OD1' ' A' ' 15' ' ' ASP . . . -57.06 161.94 7.74 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.588 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 38.9 mtm-85 -153.81 -164.12 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.719 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.88 -78.79 1.41 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -53.52 -38.83 83.79 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.86 2.373 . . . . 0.0 112.317 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.82 152.39 5.67 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.477 ' HA3' ' HE ' ' A' ' 22' ' ' ARG . . . -173.35 -178.36 43.27 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 110.765 -179.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -93.02 -45.58 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.593 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.882 HD11 ' HB2' ' A' ' 16' ' ' TYR . 3.7 tp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.5 tp10 -109.23 -10.66 14.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.4 m -84.4 165.84 36.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.61 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 7' ' ' SER . 46.4 Cg_exo -53.69 -38.36 84.54 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.763 2.308 . . . . 0.0 112.023 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.897 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.667 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 24.6 Cg_exo . . . . . 0 C--N 1.301 -1.945 0 C-N-CA 122.763 2.309 . . . . 0.0 112.158 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.912 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 12.5 t-20 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.629 0.252 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.576 ' OD2' ' CG2' ' A' ' 3' ' ' ILE . 61.6 t0 -156.72 -87.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.378 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.882 ' HB2' HD11 ' A' ' 3' ' ' ILE . 22.8 t80 -68.57 130.73 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt 68.7 10.2 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.256 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.7 tttp . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.783 0.325 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.92 156.03 20.02 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 62.5 ttp180 -61.61 -43.12 99.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.22 126.14 9.23 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.99 156.06 47.74 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.944 2.43 . . . . 0.0 112.39 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.33 145.08 18.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 63.72 27.58 71.3 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.219 0.533 . . . . 0.0 111.18 -179.421 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -83.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.528 HG12 ' OD2' ' A' ' 15' ' ' ASP . 10.7 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.273 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.522 ' HA3' ' CG ' ' A' ' 22' ' ' ARG . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.52 -5.32 22.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -58.38 -175.51 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 45.7 Cg_exo -53.27 -38.08 81.44 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.746 2.298 . . . . 0.0 111.896 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.649 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.411 ' C ' ' N ' ' A' ' 14' ' ' ASN . 18.5 Cg_endo . . . . . 0 C--N 1.306 -1.692 0 C-N-CA 122.608 2.205 . . . . 0.0 111.009 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.851 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 2.0 t-20 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.761 0.315 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.623 ' O ' ' C ' ' A' ' 16' ' ' TYR . 67.6 t0 176.92 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.623 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 9.25 -82.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.266 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ASP . 68.5 mttm -138.63 29.61 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.455 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' CE ' ' OD1' ' A' ' 14' ' ' ASN . 16.6 mttm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.968 0.413 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.55 125.35 2.79 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.522 ' CG ' ' HA3' ' A' ' 5' ' ' GLY . 62.2 ttp180 -63.41 -43.06 98.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.741 0.305 . . . . 0.0 110.692 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.68 -120.68 1.65 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.32 -38.7 82.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.717 2.278 . . . . 0.0 112.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.31 126.28 1.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' TYR . . . -133.63 -68.89 0.08 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.667 ' SG ' ' C ' ' A' ' 18' ' ' CYS . 43.3 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.638 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -79.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.419 . . . . 0.0 109.934 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.541 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 1.2 mp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.901 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.3 tp10 -106.37 -11.32 16.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 110.604 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.521 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 1.3 m -60.92 125.8 84.23 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -53.51 -39.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.859 2.373 . . . . 0.0 112.141 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.042 0.448 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.563 ' C ' ' N ' ' A' ' 14' ' ' ASN . 11.8 Cg_endo . . . . . 0 C--N 1.301 -1.931 0 C-N-CA 122.792 2.328 . . . . 0.0 111.817 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.563 ' N ' ' C ' ' A' ' 12' ' ' PRO . 66.2 t30 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.666 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 30.2 t0 175.07 173.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.78 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.666 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 16.9 p90 48.71 11.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 51.3 mttt 150.33 45.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.437 0.46 . . . . 0.0 110.532 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 20' ' ' LYS . 1.1 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.9 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.574 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -158.34 -142.52 3.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -61.12 -42.44 98.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.653 0.263 . . . . 0.0 110.54 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.94 -71.16 0.1 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.54 -20.25 47.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.872 2.381 . . . . 0.0 112.105 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 21' ' ' GLY . . . -168.11 -141.14 3.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 21' ' ' GLY . . . 86.66 13.65 66.95 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 110.643 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.492 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -67.07 -46.65 73.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 110.002 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.629 ' O ' ' C ' ' A' ' 4' ' ' DBB . 50.3 pt -130.29 3.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.198 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.629 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -133.57 -127.87 2.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.806 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.1 10.75 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.598 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -86.88 -175.04 0.54 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.1 Cg_exo -52.63 -38.38 75.99 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.745 2.297 . . . . 0.0 112.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 134.08 -124.58 3.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.674 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . 26.53 69.24 0.45 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.566 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.57 ' O ' ' HB3' ' A' ' 13' ' ' DBB . 29.5 Cg_endo -65.97 -13.43 39.79 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.008 2.472 . . . . 0.0 111.417 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.571 ' O ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.2 t-20 -135.69 35.84 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.781 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.569 ' OD1' ' CG ' ' A' ' 13' ' ' DBB . 53.7 p-10 -135.78 -147.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.551 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . 15.7 p90 -76.28 34.11 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.211 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 27' ' ' CYS . 67.6 mttm -153.44 18.18 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.947 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 27' ' ' CYS . 3.5 m -155.35 34.96 0.37 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.564 ' C ' ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.7 mttt -139.9 148.63 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.641 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 118.8 -158.3 14.88 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -128.98 147.84 50.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.08 143.53 4.07 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.54 -38.34 83.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.811 2.341 . . . . 0.0 112.001 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.55 -163.11 10.1 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 16' ' ' TYR . . . 69.27 105.31 0.03 OUTLIER Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' SG ' ' CE1' ' A' ' 28' ' ' TYR . 8.6 t -128.73 -72.62 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.707 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 98.8 m-85 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.554 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -59.42 -41.29 89.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.61 HD13 ' O ' ' A' ' 10' ' ' DAL . 10.0 tp -109.91 2.75 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.267 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.91 -122.44 2.76 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 81.3 tt0 -88.2 -9.97 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 0.0 110.377 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER 57.39 52.17 5.5 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 7' ' ' SER . 34.1 Cg_endo -66.73 -20.29 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.818 2.345 . . . . 0.0 112.128 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . 166.46 55.78 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.61 ' O ' HD13 ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . . . 62.45 57.58 2.55 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.513 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.66 ' O ' ' HG2' ' A' ' 13' ' ' DBB . 37.1 Cg_endo -69.26 -10.22 28.39 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.009 2.473 . . . . 0.0 111.692 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.66 ' HG2' ' O ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' O ' ' A' ' 20' ' ' LYS . 9.6 t30 -122.37 -1.72 9.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.676 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.632 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 27.5 t0 -162.03 176.1 11.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.857 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HD2' ' HB2' ' A' ' 17' ' ' LYS . 60.3 t80 54.25 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.866 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.58 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 8.7 ttmt -111.87 62.83 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.742 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.632 ' SG ' ' O ' ' A' ' 15' ' ' ASP . 1.3 m -155.92 139.32 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.644 ' H1 ' ' H ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' CYS . 75.7 mmtt -116.14 119.57 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.43 95.17 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.553 ' O ' ' O ' ' A' ' 23' ' ' GLY . 72.8 ttp85 -63.57 -42.91 98.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -54.08 -129.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.16 -38.17 80.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.794 2.329 . . . . 0.0 112.22 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 -142.51 17.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.23 161.58 36.68 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 5.5 t -124.63 170.59 10.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.588 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.676 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 38.9 p90 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.694 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 10' ' ' DAL . 53.7 t -47.39 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.119 HD11 ' O ' ' A' ' 9' ' ' GLY . 3.6 mp -90.57 -39.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.16 22.08 79.23 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 97.9 mt-10 -135.32 16.6 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.652 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.57 176.51 2.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.645 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 46.1 Cg_exo -53.11 -39.49 79.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.828 2.352 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 1.119 ' O ' HD11 ' A' ' 3' ' ' ILE . . . 146.15 -160.68 28.21 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.71 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . 37.82 71.49 1.02 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.536 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.69 ' C ' ' HG2' ' A' ' 13' ' ' DBB . 19.2 Cg_endo -60.2 -18.77 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.023 2.482 . . . . 0.0 111.847 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.69 ' HG2' ' C ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.561 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 62.4 t-20 -118.26 13.83 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.523 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.822 ' HA ' ' HG2' ' A' ' 19' ' ' DBB . 52.4 p-10 -128.92 -140.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.956 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 52.3 p90 -37.13 139.16 0.24 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 98.6 mttt 49.15 14.28 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.666 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 0.7 OUTLIER -137.42 -16.08 1.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.467 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.822 ' HG2' ' HA ' ' A' ' 15' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 56.2 mtmt 66.0 20.05 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.381 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' N ' ' HG3' ' A' ' 19' ' ' DBB . . . -139.13 -167.85 11.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 7' ' ' SER . 24.8 tpt180 -115.2 132.05 56.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 6' ' ' GLU . . . 125.26 153.77 8.59 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.55 155.79 54.5 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.914 2.409 . . . . 0.0 112.102 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . 118.47 170.2 14.79 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 25' ' ' GLY . . . -26.88 89.75 0.01 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 1.7 t -149.07 155.56 40.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.825 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CG ' ' C ' ' A' ' 27' ' ' CYS . 6.1 m-85 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.479 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 4' ' ' DBB . 2.7 t -79.86 131.35 35.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.153 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.606 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.1 mp 63.05 0.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.885 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.606 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -129.86 -144.18 5.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 7' ' ' SER . 19.6 pt-20 -105.47 -6.61 19.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 9.9 p -38.2 154.36 0.13 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 -20.8 55.15 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.822 2.348 . . . . 0.0 111.957 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 10' ' ' DAL . . . 172.35 -168.39 41.46 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.643 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . -111.36 71.87 0.88 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.157 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 35.5 Cg_exo -48.54 135.32 26.93 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.395 2.063 . . . . 0.0 111.508 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.539 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 23.1 t-20 -148.59 13.4 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.565 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 7' ' ' SER . 11.4 t70 -138.88 -46.23 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.649 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 52.0 p90 -135.93 137.53 41.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 57.8 mtpt 61.61 29.17 18.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -130.89 -22.53 2.6 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.442 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.589 ' CG ' ' O ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 68.9 mttm -95.37 -8.3 36.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.448 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 15' ' ' ASP . . . -98.29 151.89 19.7 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 89.0 mtm180 -64.56 -39.25 93.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.559 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.04 106.09 0.42 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 36.7 Cg_endo -67.99 -17.91 46.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.845 2.364 . . . . 0.0 112.188 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.6 95.98 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 17' ' ' LYS . . . -120.32 109.83 1.66 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.721 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 35.0 t -137.23 125.79 23.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.82 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.721 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.11 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.642 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -81.96 -47.5 12.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 110.369 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.683 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 11.1 tp -97.22 -5.18 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.183 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.506 ' HG1' ' HB2' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' H ' HG23 ' A' ' 3' ' ' ILE . . . -123.89 -148.64 7.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.564 ' OE2' ' O ' ' A' ' 22' ' ' ARG . 17.2 pt-20 -108.95 -8.2 15.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 8' ' ' PRO . 24.4 m -120.15 72.29 18.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.683 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 7' ' ' SER . 48.8 Cg_exo -50.72 -145.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.866 2.377 . . . . 0.0 112.439 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.32 16.8 70.6 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.575 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.599 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . 25.86 58.12 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.822 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.68 ' O ' ' HG2' ' A' ' 13' ' ' DBB . 22.4 Cg_exo -60.9 -3.4 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.101 2.534 . . . . 0.0 111.733 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.68 ' HG2' ' O ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 20' ' ' LYS . 54.4 t30 -118.53 -11.97 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.764 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 3.1 m-20 -157.43 169.57 24.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.566 ' HB2' ' CG1' ' A' ' 3' ' ' ILE . 65.2 t80 77.45 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.704 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.569 ' O ' ' O ' ' A' ' 27' ' ' CYS . 72.5 tttt -118.95 33.28 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.8 OUTLIER -120.85 147.01 45.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.785 ' H1 ' ' H ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 14' ' ' ASN . 64.5 mttp -110.01 149.92 29.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.537 ' HA2' ' OD2' ' A' ' 15' ' ' ASP . . . 125.97 163.17 11.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.564 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mtt-85 -128.13 149.29 50.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.688 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.85 -106.86 1.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -54.34 -34.71 81.54 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.11 10.83 70.87 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -62.83 148.93 49.67 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' O ' ' C ' ' A' ' 28' ' ' TYR . 9.6 t -124.3 165.69 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.69 0.281 . . . . 0.0 110.53 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.785 ' H ' ' H1 ' ' A' ' 19' ' ' DBB . 99.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.812 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.994 HD12 ' CB ' ' A' ' 7' ' ' SER . 67.0 mt -65.55 -42.83 93.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.799 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.516 ' HG1' ' HB2' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.42 -110.45 1.53 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 83.6 tt0 -113.65 -7.28 13.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.994 ' CB ' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -56.13 145.25 56.53 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.26 -21.17 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.885 2.39 . . . . 0.0 112.096 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.658 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 156.34 -158.55 28.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.658 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . 38.1 66.96 2.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.593 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.616 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.1 Cg_endo -58.02 127.11 23.77 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.789 2.326 . . . . 0.0 111.723 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.62 ' C ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.0 t30 -103.5 -40.42 6.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.597 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.595 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 32.5 m-20 -142.03 145.1 34.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 3.7 t80 87.63 87.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 99.5 mttt 68.13 -8.82 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.709 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.62 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 96.8 m -64.35 -35.31 80.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.365 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.556 ' HB3' ' C ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 23.5 tptm -105.56 -4.0 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.52 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 28' ' ' TYR . . . -59.62 136.8 50.21 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 78.3 ttt-85 -133.85 125.86 29.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.67 -71.04 0.22 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 55.3 Cg_endo -73.02 160.57 45.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.89 2.393 . . . . 0.0 112.17 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' HA2' ' OH ' ' A' ' 28' ' ' TYR . . . -57.22 140.59 44.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.554 ' C ' ' CE2' ' A' ' 28' ' ' TYR . . . 149.58 -171.14 29.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.63 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 31.0 p -82.8 135.27 35.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.525 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.63 ' CD2' ' O ' ' A' ' 27' ' ' CYS . 4.2 p90 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.664 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.676 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.0 m -60.03 -46.08 90.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.696 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.03 HD12 ' CB ' ' A' ' 7' ' ' SER . 96.6 mt -100.89 -41.19 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.169 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.676 ' N ' ' SG ' ' A' ' 1' ' ' CYS . . . 75.12 23.0 75.47 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HB3' ' HD3' ' A' ' 24' ' ' PRO . 76.4 mm-40 -116.27 -4.56 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.817 0.341 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 1.03 ' CB ' HD12 ' A' ' 3' ' ' ILE . 1.3 m -142.33 166.45 21.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 29.3 Cg_endo -64.77 -21.85 64.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.95 2.433 . . . . 0.0 111.77 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.672 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 149.69 -158.7 27.77 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.672 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 25.04 71.64 0.36 Allowed Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.801 ' C ' ' HG3' ' A' ' 13' ' ' DBB . 11.3 Cg_endo -56.34 -88.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.761 2.307 . . . . 0.0 111.786 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.801 ' HG3' ' C ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.883 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 48.4 t30 -98.66 -3.29 36.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.954 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 78.6 m-20 -155.19 -84.77 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 111.168 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.644 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 17.6 t80 -69.29 135.5 50.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.921 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 28' ' ' TYR . 98.1 mttt 68.75 18.88 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -146.15 150.23 35.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.425 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.64 ' O ' ' HG2' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 14' ' ' ASN . 64.4 mttp -92.14 -5.89 51.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 15' ' ' ASP . . . -66.34 81.28 0.11 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 23' ' ' GLY . 79.6 mtp85 -65.3 -37.63 87.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -53.06 -134.61 0.0 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -52.87 -39.18 78.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.719 2.279 . . . . 0.0 112.231 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.69 -120.73 1.09 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' LYS . . . 71.06 63.92 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' C ' ' A' ' 28' ' ' TYR . 6.3 t -83.29 143.06 30.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 110.593 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.56 ' C ' ' O ' ' A' ' 27' ' ' CYS . 39.2 p90 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.757 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.539 ' HB3' ' C ' ' A' ' 9' ' ' GLY . 1.6 t -78.38 -74.07 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.612 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.746 HG21 ' HB3' ' A' ' 11' ' ' ALA . 11.3 tp -104.72 25.03 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.352 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.652 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -83.16 -130.94 1.68 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.88 4.56 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.607 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -166.88 -67.0 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.722 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.66 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 54.1 Cg_endo -70.43 151.02 65.0 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.767 2.311 . . . . 0.0 112.199 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -85.72 -125.02 1.55 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.666 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 24.36 64.58 0.41 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 14' ' ' ASN . 38.3 Cg_exo -54.24 136.81 69.6 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 122.664 2.243 . . . . 0.0 110.972 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.637 ' C ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.79 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 7.2 t30 -103.49 -36.98 7.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.625 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.543 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 87.0 m-20 -143.16 155.66 44.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.78 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER 81.33 79.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.483 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 63.8 mttp 68.35 -5.18 0.95 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.754 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.637 ' HB3' ' C ' ' A' ' 13' ' ' DBB . 93.2 m -64.55 -44.41 90.86 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.79 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 14' ' ' ASN . 7.6 tttm -152.54 72.1 0.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 27' ' ' CYS . . . -163.28 138.45 5.33 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -81.7 -20.54 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.835 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 28' ' ' TYR . . . -42.88 144.15 1.26 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.25 -25.04 64.89 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.856 2.37 . . . . 0.0 112.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.639 ' C ' ' CE1' ' A' ' 28' ' ' TYR . . . -96.82 146.36 18.25 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 28' ' ' TYR . . . 35.24 -160.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' O ' ' O ' ' A' ' 21' ' ' GLY . 97.6 m -64.91 -38.64 91.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.424 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.639 ' CE1' ' C ' ' A' ' 25' ' ' GLY . 14.5 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.595 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -87.74 -45.28 10.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.011 HD13 ' OD2' ' A' ' 15' ' ' ASP . 3.0 tt -119.78 9.31 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.662 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.633 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -131.13 -124.58 2.6 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.0 tp10 -107.72 -10.05 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.225 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -74.44 154.06 87.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.577 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.31 -20.79 55.17 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.814 2.342 . . . . 0.0 112.062 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . 165.36 -162.3 35.64 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -112.69 76.97 2.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 14' ' ' ASN . 17.1 Cg_endo -59.05 143.27 99.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.586 2.191 . . . . 0.0 111.578 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.673 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.614 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 66.3 t30 -118.93 4.81 11.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 1.011 ' OD2' HD13 ' A' ' 3' ' ' ILE . 64.5 t0 -142.52 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.669 ' HB2' HD11 ' A' ' 3' ' ' ILE . 23.4 t80 -80.05 131.29 35.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.573 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 15.4 tttp 78.84 1.49 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.673 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 1.3 m -132.98 120.94 22.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.326 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.693 ' O ' ' HG2' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -64.35 -43.75 93.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.813 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 14' ' ' ASN . . . -68.04 -42.8 83.97 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HA ' ' CG ' ' A' ' 19' ' ' DBB . 76.0 ttt180 55.52 79.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.693 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.62 -163.4 11.83 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.91 -21.54 57.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.895 2.397 . . . . 0.0 112.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.9 -156.19 7.45 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . 62.94 -130.47 42.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.574 ' O ' ' C ' ' A' ' 28' ' ' TYR . 14.8 t 71.52 138.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.598 ' CE1' ' HA ' ' A' ' 19' ' ' DBB . 93.6 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.752 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.503 ' C ' ' H1 ' ' A' ' 4' ' ' DBB . 72.1 m -88.81 -74.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.393 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.66 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.2 mp -70.91 -3.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.66 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.609 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -165.45 -16.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -93.61 -66.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.307 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 155.8 -64.15 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.76 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 35.3 Cg_endo -67.26 -17.38 49.91 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.967 2.444 . . . . 0.0 112.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.653 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 72.22 -128.63 13.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.653 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' C ' ' O ' ' A' ' 10' ' ' DAL . . . 26.99 66.15 0.54 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.406 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 14' ' ' ASN . 15.3 Cg_endo -58.4 134.71 63.1 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.515 ' C ' ' O ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 12' ' ' PRO . 47.6 t30 -115.48 0.71 13.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.673 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.582 ' OD1' ' CA ' ' A' ' 21' ' ' GLY . 31.2 t70 -155.08 -86.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.645 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 56.8 t80 -70.96 131.48 43.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 23.4 mtpt 61.43 33.14 18.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.046 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -136.7 -18.82 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.582 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.621 ' O ' ' HG2' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.8 -5.7 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.675 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -96.82 120.79 6.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' GLY . 90.1 mtm180 -96.87 0.63 49.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' ARG . . . -55.69 -152.74 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.45 -39.32 82.43 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.839 2.359 . . . . 0.0 112.153 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.79 -167.84 38.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.597 ' HA3' ' CD1' ' A' ' 16' ' ' TYR . . . 99.81 103.67 2.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 28' ' ' TYR . 7.6 t -135.67 133.78 38.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 110.665 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.58 ' N ' ' N ' ' A' ' 18' ' ' CYS . 95.1 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.627 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -79.8 -46.03 17.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.333 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.672 ' O ' ' C ' ' A' ' 4' ' ' DBB . 4.2 tp -121.42 5.79 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.488 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.672 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.619 ' N ' ' CG ' ' A' ' 4' ' ' DBB . . . -160.81 -148.88 5.42 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -100.83 -5.93 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.06 0.457 . . . . 0.0 110.1 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -72.11 176.4 2.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.377 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 9' ' ' GLY . 56.1 Cg_endo -71.77 159.23 51.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.66 2.24 . . . . 0.0 111.88 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.689 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -51.71 -156.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.689 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 45.69 61.99 11.6 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ASN . 32.9 Cg_exo -51.91 135.06 50.26 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.54 2.16 . . . . 0.0 111.036 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.524 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' PRO . 35.6 t30 -119.19 -1.64 10.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.698 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' A' ' 16' ' ' TYR . 54.0 p-10 -150.2 -136.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.561 ' CD1' HD12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER 26.68 -93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.592 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ASP . 56.5 mtmt -130.09 76.06 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.782 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 3.1 m -135.14 -1.74 2.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.46 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.492 ' HB3' ' H ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 58.1 tptt -147.67 147.03 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.578 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.635 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 114.99 171.45 16.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -131.62 146.36 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.48 151.73 8.3 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.99 144.81 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.977 2.451 . . . . 0.0 112.1 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.79 152.9 22.77 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.77 -172.59 14.47 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.635 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -57.39 -178.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CD2' ' O ' ' A' ' 27' ' ' CYS . 55.6 p90 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 8' ' ' PRO . 10.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.4 -37.69 10.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.173 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.86 HD11 ' HB2' ' A' ' 11' ' ' ALA . 40.0 mt -103.86 -1.46 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.963 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.675 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -129.62 -97.01 0.81 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.26 -5.49 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.648 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -173.13 80.69 0.41 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.341 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 12.1 Cg_endo -56.53 -41.46 75.8 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 112.212 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . 34.75 24.62 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.618 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.86 ' HB2' HD11 ' A' ' 3' ' ' ILE . . . 38.92 62.91 4.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.767 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' O ' ' HB3' ' A' ' 13' ' ' DBB . 31.5 Cg_endo -66.74 -19.5 53.29 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.888 2.392 . . . . 0.0 111.747 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.593 ' HG3' ' H ' ' A' ' 15' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' OD1' ' CB ' ' A' ' 20' ' ' LYS . 65.0 t30 -120.47 17.83 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.971 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.69 ' OD2' HG23 ' A' ' 3' ' ' ILE . 63.8 t0 -141.52 -107.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.137 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 18' ' ' CYS . 39.7 p90 -53.94 144.67 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.772 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 99.0 mttt 32.61 30.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.594 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' TYR . 1.1 m -141.44 -27.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.613 ' HG2' ' HA ' ' A' ' 15' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 57.8 mtpt 52.07 27.43 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.191 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.92 173.09 42.83 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -112.28 131.65 55.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.7 -118.6 0.88 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 25' ' ' GLY . 59.9 Cg_endo -73.2 157.4 50.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.823 2.349 . . . . 0.0 112.183 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 24' ' ' PRO . . . -51.52 -162.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 17' ' ' LYS . . . 82.27 20.34 62.74 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.568 ' HA ' ' CA ' ' A' ' 19' ' ' DBB . 0.0 OUTLIER -99.72 139.22 35.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.432 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.512 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.646 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.746 ' O ' ' HG2' ' A' ' 4' ' ' DBB . 2.7 t -79.01 134.48 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.654 HG23 ' O ' ' A' ' 3' ' ' ILE . 1.8 tp 54.63 9.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 123.309 0.381 . . . . 0.0 110.246 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.746 ' HG2' ' O ' ' A' ' 2' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 3' ' ' ILE . . . -108.88 -158.73 19.03 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -103.86 -5.01 22.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 110.52 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.13 172.79 1.72 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -53.39 -38.18 82.38 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.866 2.377 . . . . 0.0 112.182 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.547 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 153.02 -164.88 31.01 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.647 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.794 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -117.78 69.24 6.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.583 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.647 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 35.2 Cg_exo -52.6 137.84 58.38 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.718 2.279 . . . . 0.0 111.782 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.658 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.794 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 61.4 t-20 -116.78 -28.15 6.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.532 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.615 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 98.7 m-20 -118.69 155.4 31.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.609 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.615 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 92.56 11.58 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.772 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 56.8 mttp 88.21 39.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.42 0.45 . . . . 0.0 110.905 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 10.9 t -82.95 -16.68 46.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 14' ' ' ASN . 57.8 mtpt -138.52 159.18 42.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.764 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.533 ' C ' ' HB3' ' A' ' 28' ' ' TYR . . . 139.89 149.35 5.33 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -94.67 -5.44 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.781 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 28' ' ' TYR . . . -80.87 159.85 42.35 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.69 143.72 47.13 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.906 2.404 . . . . 0.0 111.979 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.06 -174.97 19.83 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.638 ' O ' ' SG ' ' A' ' 27' ' ' CYS . . . 65.59 28.45 73.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.638 ' SG ' ' O ' ' A' ' 26' ' ' GLY . 2.1 p 51.94 11.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.549 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 26' ' ' GLY . 11.6 m-30 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.702 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.727 ' CB ' ' H ' ' A' ' 10' ' ' DAL . 3.1 m -63.44 -45.07 92.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.224 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.744 HD12 ' OG ' ' A' ' 7' ' ' SER . 85.5 mt -117.86 -29.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.381 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.87 25.82 55.04 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -108.8 -4.15 17.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.369 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.744 ' OG ' HD12 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -143.75 -175.48 0.48 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.763 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 47.4 Cg_exo -52.4 -38.2 73.35 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.991 2.46 . . . . 0.0 112.064 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.647 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 118.48 168.49 14.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.727 ' H ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.711 ' HB3' HD11 ' A' ' 3' ' ' ILE . . . -112.07 75.33 1.56 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 110.488 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.23 142.07 97.1 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.849 2.366 . . . . 0.0 111.915 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.708 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.69 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 63.6 t30 -125.66 123.89 39.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.437 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.74 ' HB2' HD13 ' A' ' 3' ' ' ILE . 1.0 OUTLIER 68.88 -76.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.794 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.675 ' O ' ' HG3' ' A' ' 13' ' ' DBB . 25.0 t80 -70.88 126.47 29.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 28' ' ' TYR . 98.0 mttt 58.29 3.67 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.708 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.8 OUTLIER -138.5 117.15 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.517 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.558 ' HG2' ' O ' ' A' ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 18' ' ' CYS . 99.3 mttt -82.48 -11.7 58.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 19' ' ' DBB . . . -106.62 -175.19 23.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.31 145.31 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.62 36.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -53.29 -38.33 81.81 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.863 2.375 . . . . 0.0 112.062 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.94 -170.05 32.2 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 79.02 11.49 85.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -47.85 -67.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 0.0 110.477 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.524 ' C ' ' HA ' ' A' ' 17' ' ' LYS . 6.5 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.625 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.432 ' CB ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -87.65 -83.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.878 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.612 HG22 ' HB3' ' A' ' 15' ' ' ASP . 5.6 pt -70.43 -42.58 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.094 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.547 ' N ' ' CG1' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 3' ' ' ILE . . . -124.11 -145.85 6.81 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.07 6.08 28.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.756 0.312 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.579 ' OG ' ' CD1' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -70.82 177.77 1.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 7' ' ' SER . 47.1 Cg_exo -53.89 -38.18 85.81 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.766 2.311 . . . . 0.0 112.014 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' ALA . . . 133.94 -110.56 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.627 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -111.04 72.31 0.81 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 110.152 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.627 ' HD3' ' C ' ' A' ' 10' ' ' DAL . 24.4 Cg_exo -50.71 142.33 32.39 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.358 2.039 . . . . 0.0 110.962 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.678 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 58.6 t-20 -156.3 19.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.561 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 17' ' ' LYS . 4.5 p-10 -119.74 94.94 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 51.0 p90 32.52 28.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.13 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.629 ' N ' ' O ' ' A' ' 15' ' ' ASP . 83.0 mttt -152.35 24.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.678 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 0.1 OUTLIER -155.9 54.33 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.736 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.516 ' C ' ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' CYS . 99.0 mttt -136.27 153.19 51.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.85 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.16 157.17 8.32 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -125.99 135.39 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.69 -103.44 1.93 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.59 150.73 51.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.877 2.385 . . . . 0.0 112.132 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.71 47.25 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 167.19 99.38 0.13 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 28' ' ' TYR . 5.2 t -119.13 119.08 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 110.574 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' H ' ' N ' ' A' ' 18' ' ' CYS . 31.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.607 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -92.62 -57.88 2.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.139 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.681 ' O ' ' C ' ' A' ' 4' ' ' DBB . 1.2 mp -79.9 -4.96 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.052 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.681 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.538 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -126.9 -120.58 2.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.86 14.53 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 69.5 p -103.35 171.65 4.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.555 ' O ' ' O ' ' A' ' 9' ' ' GLY . 23.9 Cg_exo -62.09 146.66 96.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 123.017 2.478 . . . . 0.0 112.014 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -43.08 177.12 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.606 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 177.37 72.49 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.223 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 14' ' ' ASN . 9.9 Cg_endo -53.09 137.33 62.61 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.874 2.383 . . . . 0.0 111.721 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.678 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.792 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 25.8 t-20 -118.67 -1.8 11.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.532 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.583 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 62.8 m-20 -161.97 175.5 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 70.0 t80 72.45 -64.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 60.6 mttm -153.92 66.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 13' ' ' DBB . 0.0 OUTLIER -151.35 47.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.655 ' H1 ' ' H ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 74.8 mmtt -126.04 145.37 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.86 112.01 1.12 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 8' ' ' PRO . 83.9 mtt85 -66.54 -38.96 88.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.756 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 24' ' ' PRO . . . -88.75 -135.0 5.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.577 ' O ' ' C ' ' A' ' 25' ' ' GLY . 36.8 Cg_endo -66.91 -19.49 52.27 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.87 2.38 . . . . 0.0 112.25 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 24' ' ' PRO . . . -19.48 130.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 16' ' ' TYR . . . -78.6 175.89 54.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.706 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 5.9 t -109.16 177.65 4.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.662 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.706 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 18.1 p90 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.778 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.584 ' SG ' ' HG3' ' A' ' 8' ' ' PRO . 9.0 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.971 ' SG ' HD13 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -95.6 -39.33 9.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.033 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.971 HD13 ' SG ' ' A' ' 2' ' ' CYS . 1.1 mp -101.21 -3.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.2 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.674 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.615 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -122.65 -110.3 2.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.4 tp10 -125.51 -13.25 6.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.9 0.381 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' PRO . 6.1 p -145.57 73.68 13.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 31.9 Cg_exo -54.92 -149.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.904 2.402 . . . . 0.0 112.202 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.22 67.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 15' ' ' ASP . . . 60.47 54.65 3.71 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.718 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 11' ' ' ALA . 37.2 Cg_endo -70.33 44.93 0.49 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.781 2.32 . . . . 0.0 112.074 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG ' ' A' ' 7' ' ' SER . 11.9 t30 -125.07 -13.1 6.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.022 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.588 ' OD1' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -156.81 66.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.599 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.563 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 4.1 t80 174.08 84.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.869 0.366 . . . . 0.0 110.491 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.542 ' H ' ' CZ ' ' A' ' 22' ' ' ARG . 97.4 mttt 53.46 7.89 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.333 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' TYR . 38.3 m -65.78 -38.19 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.391 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.577 ' HB3' ' N ' ' A' ' 28' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.629 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 60.5 tptt -107.24 159.7 16.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.484 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' OD1' ' A' ' 15' ' ' ASP . . . -57.06 161.94 7.74 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.603 ' HB2' ' CE2' ' A' ' 28' ' ' TYR . 38.9 mtm-85 -153.81 -164.12 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.719 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.88 -78.79 1.41 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -53.52 -38.83 83.79 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.86 2.373 . . . . 0.0 112.317 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' CA ' ' OH ' ' A' ' 28' ' ' TYR . . . 147.82 152.39 5.67 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' N ' ' CZ ' ' A' ' 28' ' ' TYR . . . -173.35 -178.36 43.27 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HB2' ' HG1' ' A' ' 19' ' ' DBB . 15.4 p -62.16 -52.06 65.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' N ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 m-30 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.673 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -93.02 -45.58 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.593 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.882 HD11 ' HB2' ' A' ' 16' ' ' TYR . 3.7 tp -109.19 5.08 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.654 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.613 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -118.77 -128.72 3.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.5 tp10 -109.23 -10.66 14.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.4 m -84.4 165.84 36.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.61 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 7' ' ' SER . 46.4 Cg_exo -53.69 -38.36 84.54 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.763 2.308 . . . . 0.0 112.023 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.659 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 174.59 -121.96 0.86 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.659 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . 25.25 62.16 0.45 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.861 ' C ' ' HG3' ' A' ' 13' ' ' DBB . 24.6 Cg_exo -53.11 -73.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.763 2.309 . . . . 0.0 112.158 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.861 ' HG3' ' C ' ' A' ' 12' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.912 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 12.5 t-20 -108.82 8.99 26.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.7 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.576 ' OD2' ' CG2' ' A' ' 3' ' ' ILE . 61.6 t0 -156.72 -87.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.378 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.882 ' HB2' HD11 ' A' ' 3' ' ' ILE . 22.8 t80 -68.57 130.73 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' OXT' ' A' ' 28' ' ' TYR . 9.0 ttmt 68.7 10.2 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.256 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -141.26 -20.7 0.77 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.623 ' O ' ' CG ' ' A' ' 19' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' DBB . 14.7 tttp 36.13 26.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.348 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' DBB . . . -126.92 156.03 20.02 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 62.5 ttp180 -61.61 -43.12 99.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.22 126.14 9.23 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.99 156.06 47.74 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.944 2.43 . . . . 0.0 112.39 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.33 145.08 18.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 16' ' ' TYR . . . 63.72 27.58 71.3 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.57 ' HA ' ' N ' ' A' ' 19' ' ' DBB . 84.1 m -102.01 147.24 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.219 0.533 . . . . 0.0 111.18 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.472 ' H ' ' C ' ' A' ' 18' ' ' CYS . 21.1 m-30 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.524 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.472 ' CB ' ' H ' ' A' ' 10' ' ' DAL . 0.1 OUTLIER -67.77 -83.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.615 ' O ' ' C ' ' A' ' 4' ' ' DBB . 10.7 tp -98.87 19.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.273 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.615 ' C ' ' O ' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.585 ' N ' ' HG2' ' A' ' 4' ' ' DBB . . . -142.88 -164.94 10.4 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.52 -5.32 22.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -58.38 -175.51 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 45.7 Cg_exo -53.27 -38.08 81.44 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.746 2.298 . . . . 0.0 111.896 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.639 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . 103.5 164.83 25.38 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.639 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -113.95 71.89 2.06 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.862 0.363 . . . . 0.0 110.176 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 13' ' ' DBB . 18.5 Cg_endo -60.38 147.33 94.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.608 2.205 . . . . 0.0 111.009 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.58 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.851 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 2.0 t-20 -136.71 43.19 2.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.488 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.623 ' O ' ' C ' ' A' ' 16' ' ' TYR . 67.6 t0 176.92 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.623 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 9.25 -82.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.266 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ASP . 68.5 mttm -138.63 29.61 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.455 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.665 ' C ' ' SG ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER -102.28 -68.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.583 ' O ' ' HG3' ' A' ' 20' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.62 ' H ' ' HB3' ' A' ' 27' ' ' CYS . 16.6 mttm 163.33 -94.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.55 125.35 2.79 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.522 ' CG ' ' HA3' ' A' ' 5' ' ' GLY . 62.2 ttp180 -63.41 -43.06 98.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.741 0.305 . . . . 0.0 110.692 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.68 -120.68 1.65 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.32 -38.7 82.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.717 2.278 . . . . 0.0 112.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.31 126.28 1.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' TYR . . . -133.63 -68.89 0.08 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.719 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 43.3 t -66.43 -111.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.719 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p90 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.636 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.638 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -79.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.419 . . . . 0.0 109.934 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.541 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 1.2 mp -65.28 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.901 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.527 ' HG1' ' HB2' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.71 -108.23 1.1 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 51.3 tp10 -106.37 -11.32 16.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 110.604 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.521 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 1.3 m -60.92 125.8 84.23 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -53.51 -39.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.859 2.373 . . . . 0.0 112.141 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 10' ' ' DAL . . . -179.75 -166.31 35.16 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' DAL . . . . . 0.663 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . 43.51 59.97 11.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.042 0.448 . . . . 0.0 110.533 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' C ' ' N ' ' A' ' 14' ' ' ASN . 11.8 Cg_endo -58.21 137.6 81.5 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.792 2.328 . . . . 0.0 111.817 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.725 ' C ' ' CB ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.555 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 66.2 t30 -137.14 15.83 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.451 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.666 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 30.2 t0 175.07 173.63 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.78 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.666 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 16.9 p90 48.71 11.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 16' ' ' TYR . 51.3 mttt 150.33 45.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.437 0.46 . . . . 0.0 110.532 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.725 ' CB ' ' C ' ' A' ' 13' ' ' DBB . 1.1 m -171.53 88.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' DBB . . . . . 0.548 ' C ' ' HG3' ' A' ' 20' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' CYS . 98.9 mttt -158.33 152.75 24.42 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.669 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.574 ' CA ' ' OD1' ' A' ' 15' ' ' ASP . . . -158.34 -142.52 3.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -61.12 -42.44 98.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.653 0.263 . . . . 0.0 110.54 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.94 -71.16 0.1 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.54 -20.25 47.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.872 2.381 . . . . 0.0 112.105 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 21' ' ' GLY . . . -168.11 -141.14 3.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 21' ' ' GLY . . . 86.66 13.65 66.95 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.551 ' SG ' ' HD1' ' A' ' 28' ' ' TYR . 1.7 t -87.24 130.8 34.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 110.643 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.551 ' HD1' ' SG ' ' A' ' 27' ' ' CYS . 12.5 m-85 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 stop_ save_